%PDF-1.3 % 36 0 obj <> endobj xref 36 44 0000000016 00000 n 0000001596 00000 n 0000001677 00000 n 0000001882 00000 n 0000002046 00000 n 0000002461 00000 n 0000002824 00000 n 0000002926 00000 n 0000003633 00000 n 0000004008 00000 n 0000004319 00000 n 0000004883 00000 n 0000005191 00000 n 0000005718 00000 n 0000005889 00000 n 0000006767 00000 n 0000007158 00000 n 0000007573 00000 n 0000007820 00000 n 0000008135 00000 n 0000008232 00000 n 0000009083 00000 n 0000009853 00000 n 0000010007 00000 n 0000010384 00000 n 0000010669 00000 n 0000011533 00000 n 0000012402 00000 n 0000012762 00000 n 0000013080 00000 n 0000013988 00000 n 0000014628 00000 n 0000016836 00000 n 0000023060 00000 n 0000026528 00000 n 0000028903 00000 n 0000031769 00000 n 0000032140 00000 n 0000033916 00000 n 0000034199 00000 n 0000036726 00000 n 0000036979 00000 n 0000037257 00000 n 0000001176 00000 n trailer <]>> startxref 0 %%EOF 79 0 obj <>stream xb```f``y  @Q@Nc2{3`.F/5R]wzZnԭhta↳Q7i483qV{9),[FG Y(lR6 \ @Z" ,/d ox.ȼ}|9"xtLYUdHc1=x7cׁe{$> endobj 38 0 obj <> endobj 39 0 obj <>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 40 0 obj <> endobj 41 0 obj <> endobj 42 0 obj <> endobj 43 0 obj <>stream H]o0+|J/#IwZ45jlys Uvvude8asɜq '&mͳ?DhM÷"a'i2IϬC89Rh+4~0(iZna4>}RL)7Vz]4e5JaGgbOͼ*:4iAbWw9xo"eXWS㮰yJ ",Cx{=ZѺI"I?l0 Kݬ(BɽMyh#^o:M۰],T }(qK]g3XO@>z~Kgm1mV!%,,떖Ȗ) [: g`00ģ0t z?jѦ"a%b~2΀X5s)GXq+A2!x=o}̶wxN) ކOz"YabNP^RxJcp ^q=]T-1T(*&wĚX?nMxV)^rN.#3$y`I endstream endobj 44 0 obj <> endobj 45 0 obj <> endobj 46 0 obj <> endobj 47 0 obj <> endobj 48 0 obj <> endobj 49 0 obj <> endobj 50 0 obj <>stream HtTM0ɕ?b`aqj,f[iJ;XX؝ys>)_zT5{nq>^޽>\[Ѭ* 7Z2u29ڝΘ\゙949w VT5oOcM]د77 ᮲Js n;i䖽CwpOmk24}rV8^5hiT.ZBWrUג7B\˔FߦRKjUŅUaܷ7G16fO.!(;bt #MNPñ)э⒵T?šd v| ƶcӔ6 S, ]BŅfa"hC(Fj}OZ--b1+mKa87ˠU0D:UFJ*OQF5R#^SdX8LQl AfЀz@ h@({ž (<ñZ:~ \ XAIAkԧRT} Drfź@0"sl@8aUEWiuw/`M33Z܎q-I ߺo{"{j㰟=-˒DZ Bn*0G{hþZE5N\ZRdH(xi8$dL73aVN0SHوM@Ӣ=?'LsHG+@]*y)#yy@z,%)y96 7QcAi2:C Ō[ M٤#oqհ[E+WFОSl SU/H͂N endstream endobj 51 0 obj <> endobj 52 0 obj <>stream hbd`ab`ddpuvvL) {XHd؁1031(1301(}W[JG*֓\Gb$c)?B~,b-a}U?\Gb$7hߍ7~o<Hnd㏎?KC~:8CCmiꌕ;z,\[s`{C֙_]X\h?9uyWm> endobj 54 0 obj <>stream hTOk ~9n҃KBCI*lT9WM~sh=wD# ꀳ[Bh,Qqʭ&&_Sg9[pf_/_qB!@@h"hz#ԥf`qRavDVHA}@Crk)Qiwayj !}$ϙ&9b>G)x endstream endobj 55 0 obj <> endobj 56 0 obj <>stream HTM0#V4Ac'N#BZ=DvIVBpJlϼy~;pI9+t]c[͒THG|\+&CD{9{c䐱ƈ~LRa M?X+Zӟbwu3!٦wCCL|hd%N'g},`sN 4y'!.GÌ@*iM)>\Eߴ?wDMOE4RXdZGҠ WH]tiƶff9>stream HTMo0 G E>,YvmsEb?`{"]$|$#-(|!|mF+R~黝n'y>$SLI H VRh:I K:]^?ֿjdEI=u@ZЗ7rģU jZ M|%uGhQa!|-gB_ M2Ge!IDm,\}ӞWds͋Vw R%ӫ&}Zb}UPL!2'nJ(q"!zau+@»7QRUcKuX?i){`fEö\PAE%B,]ᲫQ5uBTo.ԐF*Vvc,)fr xu-ix*h`[G >,b_3 ,aVl.2؄S"3QJL_7H g= mِ,5m/uhpNd|sσG԰mƞm%NS yJQG|x_GSR3<&NtXf3+rX+(,z`h#?6In-3ƴ#vF4GbsxvQ<v7GqL퉝$S?")Cwn a endstream endobj 58 0 obj <> endobj 59 0 obj <> endobj 60 0 obj <> endobj 61 0 obj <>stream HtTK0)&!$NX Mv,NcԉSU]b{`UW62^k2ǝ(DVeH:JTr<@[ da>/eFd+yU:/Z\ euS~ U60P,>G]pƝJ.JӃɹ!<^mQ(¼6`!B\^t%oE۔FaضE *?:zLax\h㷂۔=J_ 6ؼhʆ9jWlu3Sz` Yh2Axi¸z⑸p>zF*.#z\`z<4fgM6S4S1&N =@>^L߈_IeEG"H>hikbbqxRJ!V#-S<|JWЦ6bOFk͸Bn(t-S|ݬ'T Өa2ڏ^Wg#iTQ!z@( ^$P^W8j$3V' |?HH h ԧ40Y?C֪M4MjŸ/L*h~8'b ?㲎J Ԗ]S?Yzڐ<ue 6mx9C"#VOܐCE%D1q,|%;FuĢVQ> Ohn^@K)bgKfE}7 endstream endobj 62 0 obj <>stream HlTr +r  Y5L@dlJ?>S7I eu{zu8Lf)9"3i`1gśx&Oۋ"+ \Ί\}r 3Zv ZRr3^=kzm{9}Q]XSe&لjF{geX f(Y"NYɼOө`#ZJT!$*5eÂ~L0 >Í|"Zu$(Q-EWجSif7uDQpj&~)ztvNjc]!ҏ&8 ˚;gKN{U)\-6v̱ה592/\tXRRT(iIsà: VQM԰mP "=SvKHㄟd(4ARVgIߩTPsȮeM7jW>S%ptAUχ>jurXUag{| }p9="r5N*OSuC%Te.Zbo8)=IOA/;5(0= `S◅ȚfB{RHK '<A"ԌPا@w\"&aG  &/ X7ᜠħNy#3d#iG 6ӧ6ѽ_S X6Khi9eYADJiI7ag4% endstream endobj 63 0 obj <> endobj 64 0 obj <> endobj 65 0 obj <>stream HlTn6+)@Q6ܤE@Qх텢g141#ޜK8ah!>=6F tZ|ny!D)J(<quFX>?zB[y'- ѨCۧ{?tvo]~\g͏H~vo*[ Ǐi$֐ӸbrLDw<鷒),Tj${/4E㴄5|1|٧5Rԯ )YwӲzhxT `u{OnW []⌰I("9#dyIv ~5(rozv܄D9#GTSaR#!T"_.VVh`kזb9>'C 1@b%ΐ(+ml[Cx'#ԓ3,"n:d"j+=Cd3j+lU0ʺdCf++UϒYR/N)nd3IUn!+j9l&FpRGQo& dX38mDZ\P@ʹ"tLZƒs!7\Ⱦ.zs{ՑzoҊBUe(v(*LP0bMUJ놚}\X74nB7Or%H݊1y Z<%G5kA |E^W4_]H&9Srbc;7aԉ endstream endobj 66 0 obj <>stream Htn@ z8*p-Һb$J BG-] Gئ'і|; BA9;?Kɷҭwe=`&v'O 5ŵF:%A.a3 6 $qZiؖO ހA }Or ]/I%K'3qz:b`^ op1ސ{fY|p,;EA9Є\+Ň\W˪ma>BT?"rC^z`A+*EL&,`pIeE_5U[s$%I=(S=k u^hzTfM: endstream endobj 67 0 obj <>stream hdT TSW} y7ةQ3 ?(Z@ O S*H"T*;تm0*`űV3~s=a75k:wݵY޳9\32d#VE yIcڏw`n^}b0rl_%f5'&e⇋;}s8Z KMb-3˔)LX-VC)a(12SɺzL)LYxh bՐ`J5XE{ޜfɲİ!-a*lc9lM#Ȩ1fve90Xfĺ0ZJQ0JƃX&߲$Y!ϖo\|]flqsIXةakF #q$% VܭǤr邕ˡ}AKTz&;փؽd~nb$j49DS»iڪ- G 8[n*٠?^&ky;W@!|^zky*d6d)6` xj;u_pC ZtkDZO#,<F|ă9{.Y,,Uqrem1 &.KAD_'"'QE4<%e_A\}J Xr8s)”>YPŝ .P { 8]JK.[_ϲE>:ԣo+ teߥBA ">;]*ǍI YkU Fss4n~TMdUг޸> >~s܏]/Up>c\rr){y#XbjQ3bŠ)~ *)zIA>S&,yP["ƺ+]3xp:!q!%SP)iFqB9>!:_LLM@BLMOmҴt|2N7U4#t7~njLn9?8:ч708PBCѡDs1쎵{S!Cn`^ {HE^!Vn߸q&M=|9ɯV޸Dd,]x7<ܣWJ~}GPp>stream h޴YtWFl$M2CIB'0M^eY ,xF&[6ncz B !@4vaw׻]}9Gvvc;߸5A񮋝=d%_x΃)cijxۿF}}vvBc&[99ح[M)v ;G;.NgwN[o9,r(wυ=781wXxGF{/~/+!/z(Q1K{Kz ږ<});GhcW*ʯw8mSnK^k$8xk1^h;F^>i%)"0%z9^g׺d\Iם΍CG XgGcixVcKYLA R_IJɬ^Go}^12c.7ZYH;] 6!_~)lHXtl5l]Q5{tC?)=m 1+#Y)_|&nĵk05kxZ:#xLƄ2QPp;Wo I2%dY|n&~ѫ6-B뻜ک3~$vyT0Et%^_']s]g]TׄO^? # Qpo`5E%P< _2kgp- E(%8> fV<@{-I1?ώ O=By;Rb nZk%,YK7wg_#U2PUXFqzYXױ~XcW;1'9!1XEs$t[f(`8HϜVO #R4z U7~rzkǀ@'bWT<A?V!@} b_``CMWu֐+!(ek" 3Ī&d uvrHK'\ a*iJQp݂~cct4@v.W*%ULpxx@& ?JMDb6\{;Al `WuVrWҿ.jP])siޮe,# $UՉ|.GrQcA'o_{c766idoE; DV>/׎^OJ:7NjNP{!㫲m[}A\ K ƒֳx_VlR&lw;dE&ޑ曒%H|U|BhuMVMkL.M*nLg) ǃMc2s4lLr'<_8Aj9UtK~LGA>ι7ɝm-["~߯Kİ{mǏ%2GS 6HS*oJTLZIt`0|7Б}=( OJW4$Tp*T< =`WW9 ã9ITlVJr|^Y,RWal- vW>˹.:'| qM\-YS˲ȗx>O(_#dԗ9I5lLEFFV٩I))l>TT #˟Y՟+rAgNZ)INkȺ`Fu|()g<,>+'06b䡜"'}?OEwvuqdW^嫋uz8h+*H\R_PV/䇽O'Wc8m?,ʿ ʇo~Lqz2|C@24wo&&2#|JHE`px4,D,̂4Ck V'"\,D`--΋EYL{kS\ 6b1@ D5=3uwCV7#kcNr,COҡ][f%u8UM2(8xLֺTl(Gv1!dHυǵf*3]]mD݆ZAAaf[ o9"LƄ2 QxR:F' '!Z7v%gvI:_*_tδs&l?#xӠb*s ~pqaXaDA(`h-AaؖJ"6ՔTTb:x N{,|  # ]jN}N|],,[m \l>4n BcXƃb(9(s5VAXX ($e`xjX,˃J{{L~eӧKSLމmN$4 DwK ƕ)+Js-\3̲t~>f5z,X02=*6d O1V.gQ+p:3HwHDy櫢1.gd8Z#j,:*)/#.cݵ!T PMZƸflFE%W9(֪ca'.`}4qP㾫)1@ 17H4v8 zR`읜ŘϚɺ:CħryAr)p+8y@VGm%M%BIEIi^/y K5tpy|t>f:ZCDf=YSx.15PȦ0l\ՆŴVܪFX_s۝R5G2"cK^&qږ*J: \"6RC*4.KM(|\H `\j(Ò"ə/`ﵝ3igLTIJm^yFn'.O}3).޺$N)h^jƟ`߃i:YT%SF<}7HEAuA9f1HsΟԷHUr"v)䧳WP4c>hR[uZuWn5;^$mӇtt\3 e7BZt#i>#v#ax]B!θ @6X$Wֺ~pT`:!Z1+ObDs5 IޑખDuUmV>RW4G[,fEY ↬)QTdJLj tq0vn1]-hsd2:2^iE?$GC SV+dU4UUۦnF:kb7sߖ"zN3:g]ˎM槃 -gFBhFrndROopAKa#: V+w1&z4RC&N'E™7ϣ{?]4o |_t(l6k "'5M٬7T@pk:513oNe$Qb̽_x;(-QM]9z66,qڹ/ż968eUvR FwoLcw&>0̢*j]YⓎ1[G`ܧ}(~=V˥vo/|7{DB pdW#|D* 镶sƒm@,סkgCDz O%lʪKCHuƝǜj㋊iXVj*OA/NG:J7&ɡ*NEGK+°x\t͚kt1wۦ-sznP`.ǝr)%u ԕXdRHt6'QXV7"y w3, 񟒰/n_>z ltZAA<ַ2l~b~~ :+:_p{6"]R)Xn4]#d)K5/>stream hޜW}TWh5rfVX?FE+RV B#BHB ! "|VqjZiuֱgک[w s9{ؙu9y~xHfzJ<<<^ λgv굢ux{JV?N8E\R9/K<=<\4]Bbzq_^*~N׉u+jxSVeNqSZL6 `PO1ӴfmZ&bu&άQk1izz'5gh1Mij 5gĚu43T$'QH$ <$K<$<$+j"͒DH$F2_*3⌒ P{YcS$ʜugVxm:={ُ^QA&ą{^yV*%wJmRNRd*dS E} 6Y/,\dg拚__Fop,= Lo..)Rߑ8%j<{GC<Ձ;ȌdTn3; T֤A8ozCy]p4{ ۤ 8LT\c"}o2s.h3ܴ3zaT0^C*pd_h+b*N4nd|8p ~W<^1&! [K1h<֚o)2Ɍ01Vrpa)U̠jlՐ3X^s}nd& =8k[uk7yk> N/U\/eZu}rxx2 g;AP>Y =$uSI7L2P$٘-6s.@`0t;66 <5:\=N7^_Uo{%6a?4{$r,$oX5tr 񡃰s=yl NI&_UQ*O>^f X -jjƒKXJ<|n:{nŒrUr*Lݔk}AKe,5&9%upT- ċuvY}^bswl<V&B+k&0lNOdÎgt?8,6"X- 'gĻ&.&KZQ hi6J,d86ѽqN~w{>*fݻ[@\g>ɵnQ9*/m"&\Y{ݔ+؂[R ( +眹y%xkd+{ARmmՓcw,ng= \χϽG]N/u8nOzZK 6 E{( NI‰N@#FҖC&Φj4\4H3}K45z2Ѽ~yYvZ4^|J蜎LHCJmܩa>dǔ^ZCn.αFNgy/D{_뙊Suw3aɵ?CuhAK 4@kdJ!yO'zP*TUdW UB ͐v[ݥ +f 5B?c(m]V&=Bw]ws`E< o"(0wˆ]R݈ZʆFq J["蠉hrkeA9Tں}WdW~[ʥDnd /.FEuV:/vײ3}~hb4:{>$b(91r,QmlU<׃Fq9dreyQMg/7 Nj ߇e(Ӯ˄qGYTa 8.r UMOa5m K+C-6(/o׌B ܄:D5v)lҪjBPkXmahB(>*,n\iv&u q kD&~-XdAوeҺ}l%3+DET! ^?UAnpJ ,70`fq$UJKc-Y NPu1kv=қ.YdJ6 K%7 @ ʵ#:HwW+cq *^@Ͻ*. bx6sJ'sQ ~bZ+G~ )OA`dXd]̺`~Y{Hgtr6Q=ת){\hpW0<h+eKMEAtðwup#Q3>8ӁEw(([x{T ,y cgy0:ߎqߵfU1^KӘiѾ~dso)iՍ@$ q~a6>u״ٖUNs{Ii䏔m{QH? _uP!N}?x 㟪q-1 <2 f./s?u\OMqk."s}f:J7}OfxDs&9"*/X#eTр9>)uXFUx)m8Yk1E E{]m43& ʼnpZjg}y3h9{(8om=YW(of |8x& %6fҚ)WT?KT3\‘ 3^'_,t˘N|ҝnp&87>stream htUkTSWGZ={2Rj;`- *@H!RޯM@BQDE |Ԃ juiv sZs5?g}ηwa>|,O˗-^𼯽*aK9x_jBYʴ]Uy)˗/KRqt~J*(Y eJ*yW,G=۟#Hu]L8R+)%_$刓*eD*KRfJ'LqL~45)E*3171ta~!`j>a1#>a[1j`6 {zxW/9mǴvOψ ¿ ~$:43jDAaYC9PdOcOwvkVvV^FZwQ;#ó3I49S<`2-9ܒ2Vod4RJLjڑMjli 1yA)60qKS;3  #dP 7.h+a*5,U^M/B2}(OJZMvjXXMWuJX(p΃C2}Kۏ?̆%q.^e` 2Q1Z7g=}rzi}RR8c#=!cgSO2|-qk?rXclEWƥQUшh$/.k<k`HBD`]Ut1y _0hcDO8vr\綴?^Px*msd=77"<|:Zx2>,7sX.=֡ׯ,H2 Qww4TkZШ A+Ne"Z~fDdDK6kJ/F#zQ !o[-ԷOz*CmfX8-Č]v+^y pAIf P(CA[$"OJ}⼺:CvTfw ~F\XJ0jiYdqrpcA|3R՘G7v#ڝ}Lٞ:݌l1۩D ה*A2?:AtFN.*)EHuv|q<غs8T\m=e0 Eߐ\ Cg,(la]-̚T-k֙i*V GѫV'Ռl4[)Qo2DU&goCµ 8}5 'By1 ,8|j?Ԑ7R ?el[˺g9I; ǡ@ȧ?CwQ7ŻDKДf4.0P^MbVKSR ;t/۷C˚S?:ebK?@l?wףb'};[}\ .RSs_J{5Mr*u骴wôzWS+&+Tlq{ܹM9=Y΢fFOOfF@W%6';֊@ S/l4D5O/AG&qE) D69=#RYX4Y1O@q=w:XY&f#0]5<_Yp#ȃ//4)#!8t@=Ȼux{ XJ>knjN܏mJYX+'-&N"2bWmgYrHlS+aL 8IfOLo iS endstream endobj 71 0 obj <>stream htV TgG$`zi< ʩrH@%( p$D$pPC"j1^M}D0GEbTR֐}oOuWuU}__ Fi(^Qn!1Cks3 &(u>‰Q(JB32LigJn]Gw[a0b󲲍t) >ۘӅ,Z붐3\*h\kNKҲtz]Ij\7-eEgdeu!:}zWIFur YiizS1_10 cP1} 3Px(%3aƫhU2 G3(1?6dylUcp}=.޶˶jQmCY/[@>ĩ-}4hfB_~ۓ9|$AsW![GrcXKbAXMNj5&j%b&BtAø 0,Q O GR~VN } /5-}sG\dPs,Ndݮm>={H΂ ` ˖-r7˳shE n`n,xsire< ƣ =J}EJAoeyt3׵0%2ba7LIE܍gm;}ZIwE/oM~N dLڏ<0b8)W6Tq p`Ͼ{gw{^h) qOuzwkkjKknQ1G|嗓D%$Kj+픊,33MW_+|HD5((@r`>f[A⛨{<4b>ft%.{q4<_H%)'/# lN6wtvFf8ʪ Ӂ0QDa<|OA}oҝu'&4VīқXrѻ.3gHBԫ;Gkx 8$n9FRqD 04~ i^}WGC*B r0HXMx$з#1-t0*y@edc-U]yQ _Sf]6(s|3m4>XA̫دrSsP] o.V\;$6KĕOлBiXf~|(?ed'Bӣn\ H{Pi5V>ܱ6YY}h?o4`!]_&-tX ^rcj!vWBg<̆,* V9u0+Y`Ijqj5=][9=Y?Z:Wq{B[\w̟,~l#ir{ T(R!u6w&zH}>< 7Qxt  茂XSN5KPCO %@+ Mqe dkŹ:J0+ce;~rq`ȅ{#O6h쵢jq.guv.sx$lDe[wmi܂nml4Kk:/.=*N-|(`(NM,BŞC'nzϥ".jXvXKKϩYrfw?SW-h/,O֯˗MeKa^t/B%VCJ>fI endstream endobj 72 0 obj <> endobj 73 0 obj <>stream hlU}TYD$ݩ3"ʧg4V@٪A46B MGh1䴶((P"B`L*"5s޻Dӹ'YLB@ -,lWĹ.G{A70/Xl N3J舟LH(!Zp!Q'Idxk)ě$Ed[ACwF7'k'b9!Pbh4 F@]iͥ8 Xs_q">_T\xKcS&-@פ\XrPy֕[;C!U[۟QdTrϩ i`[kIQVw%^IkQh}W\D^GR?D5 FӕWo6ICM=&zVSҹd̒nҀ=cW9Jc+2/<:ِ4U:> endobj 75 0 obj <>stream hlyp?Yi m7v]Cf& Php$N ĉcpl˗|IuZ˺dYKɊȎW 8 &6aZG:a20e{_-y-))yK;H3xj md:u߷:3?8$!4$c4S4Z:vp&$ڱ$Zf6*-FN%}n$F(}IɸeerL%^H J# R,\QL'127!k"׮kK>\!qrҝĖ3-\]ZboYH|i ǛQ|8j&h^aɶ rSj7{BM:;ȇv(|~{qJ ;ږD 9+_9~;uKT,՚tDn,b,Q@`^[kU3 Mǃcq"어BsIaR͚zzBs9dnjÚN6݈6f̳{أM1`-ZJRS Uy Y2 r6.=aݖ>VYe:Jn[kvB !CCVt;$&6,^fT{(˶K̴պ92726P^[G?KĀ+h" H'7;I7Uv>x[_9ZcnIң '.WWV;"$ÂZ, \GI_TƐ{^.O0|ݮ0i4єkvsҺ:!B &ⵖ!jNw9ep3zB8j\/y_E:P jDgp|.G6AT6!g;?h̛ĵDTR<~E4OLҏicodyTgOr3l|ǝ3D{d2smF:OwO;&jw>L&8S,i#\ +dq\FaF-m?ϛ@lZ%"(%fNK蟖hc@""hv7Ul6Z1Aa-[_&ZkQ[02 hxAF"j Cž|`t k;ROCiqǷn,N^C}@PrrJ CMAlշ0V"SHZ|5W*)q$2+\Il':A%Gd]z&[h(<I9Wِ>}Wb3! J"NvN祸sgNeRu+ps%5KˍrOJ4'Zղ9.{Akov#[}CgޓoƦ4776B31 W" rBpXUI9ʌߡGy6'{pc30ʬ2k2Iˬ6]^'!K28=u[OAԺY kX?H4=Kx QGAV8D.fR2h`KB KllǺ@\aW"fGiLP-3oB ]e=7G|14he9LB1'P,AFZ jZ>%=mxLGS+va"<꭮u5Zћ[\W?6Mΐg힀>/A_Da/R8ѽI1Gy r?1}zRԻ'ׇWh;WM/9*ZQ40el.!Qf:u72_  -qӬkxRR<-O[Q|9fg{ߎ2&}k#Nku >:tvV| 7mO)"4 yř⧘ tjbB5M.^Fb=8-| 虉 3D#x9n"WYLrFS.V0JjEyފzpg(z@gG#CY%UOV16`pŽ%9B 1) $l.G|m}Y$7ȌR3[םdJ0yCm2iy֧cJ xyωb稕'i@UK`^A@f"P"8\S1jBdD:%'jcį7t~PQqe&f~NC`~2 endstream endobj 76 0 obj <> endobj 77 0 obj <>stream ECKEHI+AdvP7C31 %|bg AdvP7C311apqfdŒŠ\q{Q9LjLD}}}h -%GHGdXIfpa endstream endobj 78 0 obj <> endobj 1 0 obj <> endobj 2 0 obj <>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 3 0 obj <>stream 0 0 0 1 k /GS1 gs 0 827.886 23.868 .28345 re f q 1 i 0 863.655 683.64 -863.64 re W n 35.49 839.792 .28345 23.863 re f 647.83 839.792 .28351 23.863 re f 659.735 827.886 23.905 .28345 re f 659.735 35.546 23.905 .28348 re f 647.83 .015015 .28351 23.909 re f 35.49 .015015 .28345 23.909 re f Q 0 35.546 23.868 .28348 re f BT /F5 1 Tf 8.9663 0 0 8.9663 97.8519 481.5495 Tm 0 Tc 0 Tw [(December)-382.4(2009)-377.4(to)-376.3(June)-378.2(2011)-377.4(in)-380(University)-379.8(Hospital)-379.2(Centre,)]TJ 0 -1.2203 TD -.0201 Tc [(Z)-5.4(a)-.6(greb,)-478.3(C)-1.3(ro)-3.9(atia)-7(.)-478.3(P)3.8(at)-7.9(ien)-4.5(t)-1.6(s)-476.7(w)-2.8(ho)-484.4(had)-478.4(a)-.6(n)-4.5(o)-3.9(ther)-482.4(proce)-7.3(d)2.2(ure)-481.6(a)-.6(lo)-3.9(ng)]TJ T* -.019 Tc [(with)-281.6(a)-284.1(c).7(holecystectomy)-282.7(\(i.e.,)-281.2(he)]TJ 13.1896 0 TD -.0198 Tc [(rn)-4.2(io)-3.6(plasty)-5.2(\))-279.5(w)-2.5(ere)-278.9(n)-4.2(ot)-285.8(in)-4.2(clud)-3.8(ed)-3.8(.)]TJ -12.0768 -1.2266 TD 0 Tc [(We)-327.7(classied)-324.2(SSI)-327.9(using)-330.2(the)-326.2(denition)-332.8(of)-325.7(the)-332.5(National)-328.8(No-)]TJ -1.1128 -1.2203 TD [(socomial)-313.8(Infections)-313.8(Surveillance)-317.4(\(NNIS\))-311.3(system)-314.8([11].)-312.7(A)-311.2(stan-)]TJ T* [(dard)-183.3(form)-184.9(was)-179.5(completed)-191.1(for)-181(each)-185.4(patient)-185.7(consisting)-187.8(of)]TJ /F10 1 Tf 23.7489 0 TD (general)Tj -23.7489 -1.2266 TD (data)Tj /F5 1 Tf 2.1182 0 TD [(\(hospital)-421(code,)-425.2(operative)-419.9(procedure)-426.3(ID,)-417.4(age)-421.1(at)-423.6(date)-420.2(of)]TJ -2.1182 -1.2203 TD [(operation,)-346.1(sex,)-347.7(date)-344.3(of)-344.7(admission,)-347.6(date)-344.3(of)-344.7(operation,)-346.1(date)-344.3(of)]TJ T* [(discharge)-400.7(or)-395.5(of)-401.6(last)-396.8(follow-up)-397.3(in)-398.9(hospital,)-398.2(discharge)-400.7(status,)]TJ 0 -1.2267 TD [(and)-372.6(NNIS)-373.6(operative)-369.3(code\);)]TJ /F10 1 Tf 12.4056 0 TD [(stratication)-372.7(and)-369.9(preoperative)-376(data)]TJ /F5 1 Tf -12.4056 -1.2203 TD [(\(endoscopic)-238.4(procedure,)-233.2(wound)-233.4(contamination)-234.6(class,)-229.2(duration)]TJ T* [(of)-610.2(operation)-615.1(in)-607.6(minutes,)-611.1(urgent/elective)-614.8(operation,)-611.7(ASA)]TJ T* [(physical)-737.1(status)-737.9(classication,)-744.2(peri-operative)-742(prophylactic)]TJ 0 -1.2266 TD [(antibiotic\);)-403.7(and)]TJ /F10 1 Tf 7.1449 0 TD [(infection)-399.3(data)]TJ /F5 1 Tf 5.9625 0 TD [(\(type)-405(of)-401.6(SSI,)-400.3(date)-401.2(of)-401.6(infection,)]TJ -13.1074 -1.2203 TD [(micro-organism)-732(isolated,)-731.4(antibiotic)-735.4(resistance)-730.1(pattern)-732.9(of)]TJ T* [(micro-organism\))-327.8([6].)-319.5(Procedures)-326.4(that)-320(started)-327.8(as)-317(laparoscopic)]TJ 0 -1.2266 TD [(cholecystectomies)-303.6(and)-290.4(were)-293(converted)-301(in)-291.4(an)-293.8(open)-291.9(procedure)]TJ 0 -1.2203 TD [(were)-280.3(classied)-286.3(in)-278.8(a)-277.7(third)-283(group.)]TJ 1.1128 -1.2203 TD [(All)-413.1(patients)-414.6(were)-413.1(followed)-409.6(up)-413.7(for)-414.9(30)-410(days)-406.6(after)-412(hospital)]TJ -1.1128 -1.2267 TD (discharge.)Tj 1.1128 -1.2203 TD [(Nor)15.5(mali)21.2(ty)-188.2(of)-186.6(dat)16(a)-189.2(dist)17(rib)16.6(uti)13.6(on)-189.5(was)-179.5(ass)16.8(esse)16.5(d)-192.7(usi)12.8(ng)-184.8(Smi)13.1(rno)18.4(v-)]TJ -1.1128 -1.2203 TD [(Kol)16.2(mog)14.2(oro)12.7(v)-437(tes)11(t,)-427(and)-429.5(ac)13.9(cord)19.5(ing)-428.6(to)-433.2(the)-427.4(re)12.1(sul)12.8(ts,)-428.3(app)16.7(rop)14.1(ria)15.2(te)]TJ T* [(para)17.9(met)14.7(ric)-281.7(tes)11(ts)-286.3(were)-280.3(app)16.7(lie)12(d.)-284.1(Diff)13.1(er)12.1(ence)16.5(s)-292.2(bet)14.2(wee)11.2(n)-294.2(ope)14.9(ra)12.4(tiv)14.2(e)]TJ 0 -1.2266 TD [(pro)14.1(cedu)15.4(re)12(s)-298.5(wer)16.7(e)-297.1(ana)16.6(lyze)17.9(d)-293.9(wit)13.3(h)-294.2(the)]TJ /F11 1 Tf 15.7567 0 TD (w)Tj /F5 1 Tf 6.7246 0 0 5.9768 244.0062 233.518 Tm (2)Tj 8.9663 0 0 8.9663 250.0157 229.4929 Tm [(tes)11(t)-291.3(wit)13.3(h)-294.2(Yate)14.9(s)-292.2(corr)15.5(ec-)]TJ 11.0272 28.1117 TD [(tio)12.2(n)-465(\(ca)13.4(teg)14.2(ori)12(ca)13.8(l)-465.1(val)15.2(ues\))-452(or)-458.7(in)12.1(depe)14.8(nd)12.6(ent)]TJ /F10 1 Tf 18.5135 0 TD (t)Tj /F5 1 Tf .3161 0 TD [(-te)11.8(st)-457(\(qu)12.7(anti)18.4(tat)12.2(ive)]TJ -18.8296 -1.2203 TD [(valu)13.8(es)11.4(\).)-212(Bina)15.9(ry)-213.8(lo)12.7(gist)15.6(ic)-211.5(reg)14(ress)15.7(ion)-212(was)-204.8(perf)16.5(orm)11.6(ed)-211.6(to)-218.2(ass)16.8(es)11.4(s)-222.6(the)]TJ T* [(impa)17(ct)-315.9(of)-313.1(a)-315.7(numb)18.6(er)-316.7(of)-313.1(fa)12.7(ctor)15.7(s)-317.5(o)0(n)-316(the)-307.3(lik)13.8(eli)12(ho)12.8(od)-315.6(tha)15.6(t)-316.6(pat)11.3(ien)12.1(ts)]TJ 0 -1.2266 TD [(wou)13.2(ld)-329(dev)15.3(elo)12.8(p)-336.5(a)0(n)-325.4(inf)11.6(ect)13(io)12.7(n.)-328.8(All)-324.6(p)-330.1(valu)13.8(es)]TJ /F6 1 Tf 18.2669 0 TD (<)Tj /F5 1 Tf .7145 0 TD [(0.05)-317.6(were)-318.3(con)13.5(sid-)]TJ -18.9814 -1.2203 TD [(ere)12.1(d)-180(sig)16(nic)16.1(ant)15.6(.)-180(Dat)11.3(a)-176.5(ana)16.6(lys)16(is)-175.6(sof)14.4(twar)16.7(e)-176.9(STAT)19.4(ISTI)13.3(CA)-172.3(\(St)13.2(atS)14.2(oft)15.3(,)]TJ T* [(Inc.)17.6(,)-274.8(ver)11.3(sio)11.4(n)-275.3(9.1)17(\))-278.7(was)-261.7(used)19.7(.)]TJ /F3 1 Tf 0 -3.0603 TD (Results)Tj /F5 1 Tf 1.1128 -1.8273 TD [(The)-436.2(incidence)-432.5(of)-433.2(SSI)-429(was)-432.4(1.44%)-433(\(12/832\).)-428.1(The)-436.2(incidence)]TJ -1.1128 -1.2266 TD [(density)-515.5(in-hospital)-510.1(SSI)-504.9(per)-514.1(1,000)-500.5(post-operative)-514.8(days)-507.8(was)]TJ 0 -1.2203 TD (5.76.)Tj /F12 1 Tf 9.9626 0 0 9.9626 596.5226 361.2471 Tm 0 1 1 0 k (b)Tj /F5 1 Tf 1.0015 0 TD (T1)Tj 8.9663 0 0 8.9663 370.3747 361.0204 Tm 0 0 0 1 k [(Table)-396.1(1)-391.5(gives)-395.6(the)-395.8(descriptive)-399.4(statistics)-396.9(and)-397.9(differences)]TJ -2.3964 -1.2203 TD [(between)-268.8(the)-263(operations.)-265.2(Signicant)-265.6(differences)-264.8(were)-267.7(noted)-262.5(in)]TJ 0 -1.2266 TD [(all)-506.1(investigated)-507(variables)-500(and)-499.1(suggested)-509.3(that)-503.3(laparoscopic)]TJ 0 -1.2203 TD [(cholecystectomy)-455.1(was)-438.7(performed)-449(more)-443.5(often)-449.6(on)-442.4(female)-443.5(pa-)]TJ T* [(tients)-236.7(\(69.7%)-224.9(vs.)-226.3(53.79%;)-226.8(p)]TJ /F6 1 Tf 11.5267 0 TD (<)Tj /F5 1 Tf .7145 0 TD [(0.001\).)-232(In)-226.8(comparison,)-230.1(most)-229.8(cases)]TJ -12.2412 -1.2266 TD [(of)-420.6(laparoscopic)-419.6(cholecystectomy)-423.4(were)-419.4(elective,)-414.8(and)-416.9(the)-421.1(pa-)]TJ 0 -1.2203 TD [(tients)-344.2(had)-341(lower)-343.6(ASA)-336.4(scores.)-343.3(Most)-344.8(of)-338.4(antibiotic)-343.4(prophylaxis)]TJ T* [(was)-628.4(administered)-635.5(when)-627.9(open)-633.4(cholecystectomy)-632.1(was)-628.4(pre-)]TJ 0 -1.2267 TD [(formed)-402.8(\(75%)-399.5(vs.)-397(12.7%\).)-398.5(The)-398.3(percentage)-400.8(of)-401.6(infection)-402.4(in)-398.9(pa-)]TJ 0 -1.2203 TD [(tients)-382.1(who)-380.8(underwent)-380.5(open)-374.1(cholecystectomy)-385.5(was)-375.5(ten)-376.8(times)]TJ T* [(that)-541.3(in)-538(patients)-541.1(who)-538.9(had)-537(a)-537(laparoscopic)-539.7(cholecystectomy)]TJ T* [(\(6.06%)-610.5(vs.)-612(0.6%;)-607.2(p)]TJ /F6 1 Tf 9.0544 0 TD (<)Tj /F5 1 Tf .7208 0 TD [(0.001\).)-605(Infections)-617.3(in)-607.6(patients)-610.6(having)]TJ -9.7752 -1.2266 TD [(emergency)-186.5(open)-184.5(procedures)-187.3(occurred)-190.4(in)-184(9.09%)-180.1(of)-180.3(cases,)-187.6(and)-182.9(in)]TJ ET 97.852 755.886 490.167 .22675 re f 97.852 518.797 490.167 .28351 re f 196.214 736.611 212.258 .22675 re f 97.852 708.945 490.167 .28345 re f BT /F8 1 Tf 8.9663 0 0 8.9663 226.3181 761.5557 Tm (Table)Tj /F5 1 Tf 3.0603 0 TD (1.)Tj /F8 1 Tf 1.2519 0 TD [(Categorical)-334.5(Values)-331.2(by)-334.1(Operative)-333.8(Procedure)]TJ /F10 1 Tf 0 -2.0423 TD [(Operative)-339.3(Procedure)]TJ -7.6697 -2.0044 TD (Cholecystectomy)Tj .8409 -1.1128 TD (N)Tj /F6 1 Tf .9358 0 TD (=)Tj /F10 1 Tf .7145 0 TD [(132)-333.7(\(%\))]TJ 9.2567 1.1128 TD [(Laparoscopic)-336.3(cholecystectomy)]TJ 3.4523 -1.1128 TD (N)Tj /F6 1 Tf .9421 0 TD (=)Tj /F10 1 Tf .7145 0 TD [(700)-333.6(\(%\))]TJ /F11 1 Tf 12.3739 1.1128 TD (w)Tj /F5 1 Tf 6.7246 0 0 5.9768 463.2944 729.2407 Tm (2)Tj /F10 1 Tf 8.9663 0 0 8.9663 469.644 725.2722 Tm [(Value)-331.6(with)]TJ -1.7641 -1.1128 TD [(Yates)-334.2(Correction)-5081.3(P)-338.1(value)]TJ /F5 1 Tf -39.7016 -2.0929 TD (Gender)Tj .999 -1.1128 TD [(Male)-9271.1(61)-334.1(\(46.21\))-9631.7(212)-333.6(\(30.30\))-11168.2(12.78)]TJ /F6 1 Tf 50.7034 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -51.4179 -1.1128 TD [(Female)-8313.1(71)-334.1(\(53.79\))-9631.7(488)-333.6(\(69.70\))]TJ -.999 -1.4416 TD (Urgency)Tj .999 -1.1128 TD [(Emergency)-6544.1(88)-334.1(\(66.67\))-10137.5(56)-327.8(\(8.00\))-11168.7(267.07)]TJ /F6 1 Tf 50.7034 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -51.4179 -1.1128 TD [(Elective)-8034.1(44)-334.1(\(33.33\))-9631.7(644)-333.6(\(92.00\))]TJ -.999 -1.4416 TD [(ASA)-336.4(score)]TJ .999 -1.1128 TD [(1)-11456.6(5)-334.6(\(3.79\))-10131.7(136)-333.6(\(19.50\))-11168.2(78.4)]TJ /F6 1 Tf 50.7034 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -51.4179 -1.1128 TD [(2)-10957.1(7)0(0)-334.1(\(53.03\))-9631.7(473)-333.6(\(67.70\))]TJ 0 -1.1065 TD [(3)-10957.1(5)0(7)-334.1(\(43.18\))-10137.5(89)-327.8(\(12.70\))]TJ 0 -1.1128 TD [(4)-11456.6(0)-334.6(\(0\))-12387(1)-328.3(\(0.10\))]TJ -.999 -1.4479 TD [(Antibiotic)-338.9(prophylaxis)]TJ .999 -1.1065 TD [(No)-10094.1(33)-334.1(\(25.00\))-9631.7(611)-333.6(\(87.30\))-10668.7(246.3)]TJ /F6 1 Tf 50.7034 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -51.4179 -1.1128 TD [(Yes)-9907.1(99)-334.1(\(75.00\))-10137.5(89)-327.8(\(12.70\))]TJ -.999 -1.4416 TD (Infection)Tj .999 -1.1128 TD [(No)-9594.6(124)-333.7(\(93.94\))-9631.7(696)-333.6(\(99.40\))-11168.2(23.5)]TJ /F6 1 Tf 50.7034 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -51.4179 -1.1128 TD [(Yes)-10406.6(8)-334.6(\(6.06\))-11137(4)-328.3(\(0.60\))]TJ 7.9702 0 0 7.9702 105.8456 507.0046 Tm (ASA)Tj /F6 1 Tf 2.2193 0 TD (=)Tj /F5 1 Tf .7184 0 TD [(American)-321.3(Society)-328.9(of)-332(Anesthesiol)6.9(ogists.)]TJ ET 97.852 198.595 490.167 .22675 re f 97.852 105.052 490.167 .22678 re f 97.852 179.603 490.167 .28348 re f BT /F8 1 Tf 8.9663 0 0 8.9663 194.7401 204.2645 Tm (Table)Tj /F5 1 Tf 3.0603 0 TD (2.)Tj /F8 1 Tf 1.2519 0 TD [(Comparison)-335.9(of)-336.4(Quantitative)-334.4(Values)-337.5(of)-330(Cholecystectomies)]TJ /F10 1 Tf -15.1181 -2.0423 TD [(Factor)-12395.7(Procedure)-2062.6(N)-1164.8(Min)-801.8(Max)-800.6(Mean)-806.2(Median)-801.3(Standard)-336.4(Deviation)-799.2(Standard)-336.4(Error)-801.1(P)-338.1(Value)]TJ /F5 1 Tf 6.7246 0 0 5.9768 584.6739 189.9212 Tm (a)Tj 8.9663 0 0 8.9663 97.8519 167.1873 Tm [(Age)-334.5(\(years\))-8947.4(Open)-4218.7(132)-1180.9(27)-1870.6(92)-1017(64.42)-1499.5(67.0)-4326.3(14.17)-5893.9(1.23)]TJ /F6 1 Tf 51.4306 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -38.1082 -1.1128 TD [(Laparoscopic)-804.8(700)-1680.4(4)-1871.1(8)0(6)-1017(53.65)-1499.5(55.0)-4326.3(14.65)-5893.9(0.55)]TJ -14.0369 -1.4479 TD [(Hospital)-334.9(length)-337.6(of)-338.4(stay)-334.5(\(days\))-799.5(Open)-4218.7(132)-1680.4(1)-1871.1(3)0(3)-1516.5(8.13)-1999.5(7.0)-4826.3(4.78)-5894.4(0.42)]TJ /F6 1 Tf 51.4306 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -38.1082 -1.1065 TD [(Laparoscopic)-804.8(700)-1680.4(1)-1871.1(3)0(3)-1516.5(2.40)-1999.5(2.0)-4826.3(1.72)-5894.4(0.06)]TJ -14.0369 -1.4479 TD [(Duration)-335.6(of)-338.4(operation)-336.9(\(min\))-1624.1(Open)-4218.7(132)-1180.9(35)-1371.1(250)-1016.5(85.80)-1499.5(78.0)-4326.3(37.17)-5893.9(3.23)]TJ /F6 1 Tf 51.4306 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001)Tj -38.1082 -1.1128 TD [(Laparoscopic)-804.8(700)-1180.9(18)-1371.1(190)-1016.5(60.34)-1499.5(55.0)-4326.3(28.34)-5893.9(1.07)]TJ 5.9774 0 0 5.3127 105.8456 96.7747 Tm (a)Tj 7.9702 0 0 7.9702 108.7937 93.2598 Tm (Independent)Tj /F10 1 Tf 5.9039 0 TD (t)Tj /F5 1 Tf .3201 0 TD (-test.)Tj /F3 1 Tf 8.9663 0 0 8.9663 97.8519 785.4801 Tm (2)Tj 45.6704 0 TD [(BOGDANIC)-333.5(ET)-338.7(AL.)]TJ /F9 1 Tf 9.9626 0 0 9.9626 65.7071 832.4218 Tm [(SUR-)-9.6(2012-096-v)-14.2(er9-Bog)-9.3(danic_1)-8.9(P.3d)-1004.2(03/)-8.6(23/13)-1009.3(11:55am)-1011.6(Page)-337.7(2)]TJ ET endstream endobj 4 0 obj <> endobj 5 0 obj <>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 6 0 obj <>stream 0 0 0 1 k /GS1 gs 0 827.886 23.868 .28345 re f q 1 i 0 863.655 683.64 -863.64 re W n 35.49 839.792 .28345 23.863 re f 647.83 839.792 .28351 23.863 re f 659.735 827.886 23.905 .28345 re f 659.735 35.546 23.905 .28348 re f 647.83 .015015 .28351 23.909 re f 35.49 .015015 .28345 23.909 re f Q 0 35.546 23.868 .28348 re f BT /F5 1 Tf 8.9663 0 0 8.9663 95.5842 761.6124 Tm 0 Tc 0 Tw [(the)-187.1(emergency)-192.8(laparoscopic)-192(group)-187.6(in)-184(3.57%.)-183(The)-189.7(open)-190.8(surgery)]TJ 0 -1.2203 TD [(group)-440.6(had)-435.9(a)-442.1(2.27%)-433(rate)-436.9(of)-439.5(infections)-441.7(and)-442.2(the)-440(laparoscopic)]TJ 0 -1.2266 TD [(group)-282.5(0.16%.)]TJ 9.9626 0 0 9.9626 67.2378 728.9573 Tm 0 1 1 0 k (T2)Tj /F12 1 Tf 1.2747 0 TD (c)Tj /F5 1 Tf 8.9663 0 0 8.9663 105.5622 728.7305 Tm 0 0 0 1 k [(Table)-339.2(2)-334.6(shows)-339.2(the)-338.9(descriptive)-336.2(statistics)-340(and)-341(differences)-340.6(in)]TJ -1.1128 -1.2203 TD [(quantitative)-447.3(variables)-443.1(between)-445.9(operational)-447.4(procedures.)-443.2(Pa-)]TJ 0 -1.2266 TD [(tients)-325.2(who)-323.9(had)-315.7(a)-322(laparoscopic)-324.7(cholecystectomy)-322.3(were)-324.6(signi-)]TJ 0 -1.2203 TD [(cantly)-194(younger)-194(\(53.65)]TJ /F6 1 Tf 9.4528 0 TD ()Tj /F5 1 Tf .7208 0 TD [(14.65)-190.7(vs.)-188.3(64.42)]TJ /F6 1 Tf 6.2723 0 TD ()Tj /F5 1 Tf .7208 0 TD [(14.17)-190.7(years;)-192.1(p)]TJ /F6 1 Tf 5.9625 0 TD (<)Tj /F5 1 Tf .7208 0 TD (0.001\),)Tj -23.85 -1.2203 TD [(spent)-676.7(one)-670(third)-668.7(as)-671.1(long)-665.4(in)-670.8(the)-674(hospital)-667.1(\(2.40)]TJ /F6 1 Tf 22.3009 0 TD ()Tj /F5 1 Tf .7208 0 TD [(1.72)-671.7(vs.)]TJ -23.0217 -1.2266 TD (8.13)Tj /F6 1 Tf 1.9158 0 TD ()Tj /F5 1 Tf .7208 0 TD [(4.78)-640.1(days;)-637.1(p)]TJ /F6 1 Tf 6.1143 0 TD (<)Tj /F5 1 Tf .7145 0 TD [(0.001\),)-643(and)-638.2(had)-644.5(signicantly)-643.1(shorter)]TJ -9.4654 -1.2203 TD [(operations)-723.9(by)-717(26)-163.4(min)-719(\(60.34)]TJ /F6 1 Tf 13.5121 0 TD ()Tj /F5 1 Tf .7208 0 TD [(28.34)-709.1(vs.)-719.5(85.80)]TJ /F6 1 Tf 7.3219 0 TD ()Tj /F5 1 Tf .7208 0 TD [(37.17)-165.4(min;)]TJ -22.2756 -1.2203 TD (p)Tj /F6 1 Tf .7651 0 TD (<)Tj /F5 1 Tf .7145 0 TD (0.001\).)Tj -.3667 -1.2203 TD [(Binary)-292.8(logistic)-290.7(regression)-296.1(was)-293.3(performed)-290.9(to)-294.1(assess)-289.2(the)-294.6(im-)]TJ -1.1128 -1.2266 TD [(pact)-417.9(of)-414.2(a)-410.5(number)-418.3(of)-414.2(factors)-415.5(on)-417.1(the)-414.7(likelihood)-416.1(that)-414.8(patients)]TJ 0 -1.2203 TD [(would)-391.7(develop)-384.3(an)-388.6(infection.)-386.4(The)-385.7(model)-386.1(contained)-388.3(eight)-391.1(in-)]TJ T* [(dependent)-305.2(variables:)-300.6(sex,)-297.1(age,)-297.6(hospital)-300.4(length)-305.9(of)-294.1(stay,)-299.5(opera-)]TJ 0 -1.2266 TD [(tion)-402.2(duration,)-397(emergency)-401.5(or)-395.5(not,)-401.6(ASA)-399.6(score,)-398.9(and)-397.9(antibiotic)]TJ 0 -1.2203 TD [(prophylaxis.)-494.9(The)-486.8(full)-489.4(model)-487.3(containing)-491.6(all)-487.1(predictors)-493.6(was)]TJ T* [(statistically)-381.3(signicant)-382.2(\()]TJ /F11 1 Tf 10.534 0 TD (w)Tj /F5 1 Tf 6.7246 0 0 5.9768 194.9669 579.288 Tm (2)Tj 8.9663 0 0 8.9663 201.7133 575.3195 Tm [(8;)-375.5(N)]TJ /F6 1 Tf 2.1119 0 TD (=)Tj /F5 1 Tf .7208 0 TD (832\))Tj /F6 1 Tf 1.9917 0 TD (=)Tj /F5 1 Tf .7145 0 TD [(50.59;)-376.9(p)]TJ /F6 1 Tf 3.6357 0 TD (<)Tj /F5 1 Tf .7208 0 TD [(0.001,)-376.9(indi-)]TJ -21.7318 -1.2266 TD [(cating)-212.9(that)-212.5(the)-212.4(model)-215.4(could)-212.3(distinguish)-212.6(between)-218.3(patients)-212.3(who)]TJ 0 -1.2203 TD [(had)-404.2(and)-397.9(did)-401.6(not)-405(have)-401.9(infection.)-405.3(The)-398.3(model)-405.1(as)-399.2(a)-397.9(whole)-403.2(ex-)]TJ T* [(plained)-349.3(30.5%)-344.5(\(Nagelkerke)-345.9(R)]TJ 6.7246 0 0 5.9768 211.8047 546.4061 Tm (2)Tj 8.9663 0 0 8.9663 215.1495 542.4376 Tm [(\))-348.2(o)0(f)-344.7(the)-345.2(variance)-348(in)-342(symptom-)]TJ -13.335 -1.2203 TD [(atology)-435.2(and)-423.2(correctly)-434.7(classied)-431.7(98.4%)-426.7(of)-426.9(cases.)-427.9(As)]TJ 9.9626 0 0 9.9626 67.2378 531.7227 Tm 0 1 1 0 k (T3)Tj /F12 1 Tf 1.2747 0 TD (c)Tj /F5 1 Tf 8.9663 0 0 8.9663 304.8377 531.4959 Tm 0 0 0 1 k [(Table)-427.7(3)]TJ -23.3379 -1.2266 TD [(shows,)-285.2(four)-277.2(of)-281.5(the)-282(independent)-280.5(variables)-278.7(made)-278.2(a)-277.7(statistically)]TJ 0 -1.2203 TD [(unique)-399.6(contribution)-399.1(to)-401.6(the)-395.8(model.)-395.4(This)-396.9(indicated)-401.3(that)-395.9(male)]TJ T* [(patients)-395.6(had)-391.6(5.11)-387.2(times)-394.8(the)-389.5(risk)-389.3(of)-395.3(developing)-389.3(SSI,)-394(patients)]TJ 0 -1.2266 TD [(who)-191.2(had)-182.9(an)-186.3(open)-184.5(cholecystectomy)-195.8(had)-182.9(4.67)-184.8(times)-186.1(the)-187.1(risk,)-189.9(and)]TJ 0 -1.2203 TD [(patients)-376.7(who)-374.5(had)-372.6(longer)-375.1(operations)-376.1(had)-372.6(1.01)-374.5(times)-375.8(the)-370.5(risk)]TJ T* [(when)-286.5(controlling)-280.7(for)-282.1(all)-284.8(other)-279.1(factors)-282.7(in)-285.1(the)-282(model.)]TJ 1.1128 -1.2266 TD [(Procedures)-339.1(that)-332.6(started)-334.2(as)-329.6(laparoscopic)-337.4(cholecystectomies)]TJ -1.1128 -1.2203 TD [(and)-252.5(were)-248.7(converted)-250.4(in)-253.5(an)-249.5(open)-247.7(procedure)-255.6(were)-248.7(performed)-253(in)]TJ T* [(28)-239.3(patients.)-240.5(The)-233.9(incidence)-242.8(of)-230.9(SSI)-239.3(in)-234.5(this)-242.6(group)-231.9(was)-236.4(17.9%.)-239.9(The)]TJ 0 -1.2266 TD [(majority)-191(procedures)-187.3(were)-185.5(elective)-190.6(71.4%,)-183(and,)-185.9(as)-184.2(expected,)-185.9(the)]TJ 0 -1.2203 TD [(operating)-477.6(time)-469.4(was)-470.3(signicantly)-478.7(longer)-470(than)-474.7(in)-474.8(other)-468.8(two)]TJ T* [(groups)-283.8(\(109.64)]TJ /F6 1 Tf 6.6011 0 TD ()Tj /F5 1 Tf .7208 0 TD [(85.36)-165.4(min\).)]TJ -6.2091 -1.2203 TD [(The)-196(pre-operative)-201(hospital)-199.2(stay)-189.1(had)-195.6(no)-195.8(impact)-197.7(on)-195.8(the)-193.4(risk)-193.3(of)]TJ -1.1128 -1.2266 TD [(infection.)-228.3(Overall,)-216.2(the)-218.7(pre-operative)-226.3(stay)-220.7(was)-217.4(0.87)-222.8(days.)-213.5(In)-220.5(the)]TJ 0 -1.2203 TD [(laparoscopic)-204.6(group,)-196.9(it)-193.7(was)-198.5(1.06)-197.5(days;)-194.5(in)-196.6(the)-193.4(open)-203.4(group,)-196.9(it)-193.7(was)]TJ T* [(0.57)-431.4(days,)-434.8(and)-429.5(in)-436.9(the)-433.7(group)-434.2(having)-432.3(laparoscopic)-432.2(cholecys-)]TJ 0 -1.2267 TD [(tectomy)-396.9(converted)-395.8(to)-388.9(an)-394.9(open)-393.1(procedure,)-391.3(it)-396(was)-388.2(0.82)-393.5(days.)]TJ 0 -1.2203 TD [(Among)-357.3(patients)-357.7(having)-350.1(infections,)-362.4(the)-351.5(pre-operative)-359.1(stay)-353.5(in)]TJ T* [(the)-326.2(laparoscopic)-331.1(group)-326.7(was)-324.9(0)-322(days,)-327.3(in)-323.1(the)-332.5(open)-323.6(group)-326.7(0.286)]TJ 0 -1.2266 TD [(days,)-283.1(and)-277.8(in)-285.1(the)-282(third)-283(group)-282.5(0.6)-280.1(days.)]TJ 1.1128 -1.2203 TD [(According)-283.3(to)-275.1(the)-275.6(distribution)-287.7(of)-275.1(risk)-275.5(index,)-280.5(the)-275.6(majority)-279.5(of)]TJ -1.1128 -1.2203 TD [(patients)-503.1(were)-501.6(classied)-501.3(in)-500.1(NNIS)-500.1(0)-499(group)-497.5(\(77.6%\),)-500.1(the)-503.3(re-)]TJ T* [(mainder)-285.8(being)-281.2(in)-278.8(NNIS)-285.1(1)-277.7(group)-282.5(\(20.8%\))-282.2(or)-281.7(NNIS)-278.8(23)-283.1(\(1.5%\).)]TJ 29.117 53.7764 TD [(Using)-393.4(the)-395.8(standard)-396.6(denition)-396(of)-395.3(the)-389.5(NNIS)-398.9(system)-397(\(lapa-)]TJ -1.1128 -1.2203 TD [(roscopic)-194.4(and)-189.3(open)-197.1(cholecystectomy\),)-192.9(66.67%)-192.3(of)-192.9(the)-193.4(SSIs)-190.1(\(8/12\))]TJ 0 -1.2266 TD [(were)-318.3(supercial,)-326.2(8.33%)-319.2(\(1/12\))-324.9(deep,)-323.2(and)-322(25%)-323.1(\(3/12\))-318.6(organ/)]TJ 0 -1.2203 TD [(space.)-282.5(In)-283.7(the)-288.3(third)-283(group,)-285.4(80%)-285.2(of)-281.4(the)-282(infections)-289.9(were)-286.6(super-)]TJ T* [(cial)-277.7(\(4/5\))-281.2(and)-284.1(20%)-278.9(deep.)]TJ 1.1128 -1.2266 TD [(In)-334.3(ten)-326.2(cas)12.5(es)11.4(,)-338(wou)13.2(nd)-328.9(swa)16.5(bs)-328.2(were)-318.3(take)14.7(n,)-328.8(and)-322.1(bac)15.8(ter)11.6(ia)-331.8(wer)16.7(e)]TJ -1.1128 -1.2203 TD [(iso)17.7(late)15.6(d)-565.7(i)0(n)-563.3(ve)-553.7(cas)12.5(es.)-560.5(In)-561.9(all)-556.7(pat)17.6(ien)12.2(ts,)]TJ /F10 1 Tf 17.9191 0 TD [(Esch)17.1(eri)15.7(chi)12.6(a)-568.3(col)12.8(i)]TJ /F5 1 Tf 7.0058 0 TD (was)Tj -24.9249 -1.2203 TD [(the)-174.5(orga)17.9(ni)12.1(sm)-182.2(re)12(cove)16.3(re)12.1(d.)-183(In)-176.2(thre)14.5(e)-183.3(pat)11.3(ien)18.5(ts,)]TJ /F10 1 Tf 17.8559 0 TD [(E.)-183(col)12.8(i)]TJ /F5 1 Tf 2.5861 0 TD [(was)-179.5(com)19.3(bin)14(ed)]TJ -20.442 -1.2266 TD [(wi)13.8(th)-446.5(coa)17.4(gula)16.5(se)11.4(-neg)17.1(ati)15.4(ve)-443.2(sta)11.3(phy)16.1(loc)13.4(occ)11.3(i,)]TJ /F10 1 Tf 17.6852 0 TD [(Ente)16.7(ro)12.7(cocc)17.4(us)-441.4(faec)18.4(ium)]TJ /F5 1 Tf 8.7319 0 TD (,)Tj -26.4171 -1.2203 TD [(or)-547.2(ext)16.4(end)12.7(ed-)15.6(spec)17.1(trum)-537.5(bet)14.2(a-la)15.9(cta)13.4(mas)14.3(e-)12.3(pos)13.5(iti)11.4(ve)-544.4(\(ESB)14(L\))]TJ /F10 1 Tf 24.5835 0 TD [(Kl)12.8(eb-)]TJ -24.5835 -1.2203 TD [(sie)15.7(lla)-325.5(pne)14.3(um)13.2(oni)13.4(ae)]TJ /F5 1 Tf 7.1196 0 TD [(.)-331.7(The)-322.4(oth)12.3(er)-329.4(swa)16.5(bs)-328.2(were)-318.3(ste)11(rile)17.6(.)-331.7(I)0(n)-328(two)-327.3(ca)13.9(ses,)]TJ /F10 1 Tf -7.1196 -1.2203 TD [(E.)-208.2(co)14.7(li)]TJ /F5 1 Tf 2.643 0 TD [(was)-198.5(resi)13.5(sta)17.7(nt)-206.2(to)-211.9(amo)12.8(xi)13.3(cil)12.6(lin)14.8(,)-211.6(and)-201.9(the)-206.1(ESB)14.5(L)]TJ /F10 1 Tf 18.1025 0 TD [(K.)-203.2(pne)14.3(umo)13.9(nia)13.4(e)]TJ /F5 1 Tf -20.7455 -1.2266 TD [(was)-261.7(sens)13.1(iti)17.8(ve)-272.5(to)-275.1(am)15.6(inog)17.5(lyco)15.3(si)14.1(des)-269.8(and)-265.1(car)13.2(bap)13.7(ene)15.8(ms.)]TJ /F3 1 Tf 0 -3.054 TD (Discussion)Tj /F5 1 Tf 1.1128 -1.8336 TD [(W)19.9(e)-297.1(su)28.9(rv)30.2(e)12.7(y)14.6(e)12.8(d)-293.9(t)12.2(h)15.6(e)-297.1(i)15.4(n)15.6(c)13.4(i)15.4(d)16(e)12.7(n)15.6(c)13.4(e)-297.1(o)16.2(f)-297.6(S)14.2(S)14.2(I)-293(a)13.1(f)18.5(t)12.2(e)12.8(r)-297.9(c)19.7(ho)25.5(l)15.4(e)12.7(c)13.4(y)20.9(st)23.5(e)19.1(c)13.4(t)12.2(o)16.2(m)15.1(y)-295.3(us)28.9(-)]TJ -1.1128 -1.2203 TD [(i)15.4(n)15.6(g)-276.3(t)12.2(h)15.6(e)-278.1(H)12.7(E)16(L)16(I)16.9(C)12.5(S)-276.7(pr)29.6(o)16.2(t)12.2(o)16.2(c)13.4(o)16.2(l)0(,)-265.7(a)13.1(s)-273.2(t)12.2(h)15.6(i)15.4(s)-279.5(o)16.2(pe)30.4(ra)25.1(t)18.5(i)15.4(ve)-266.2(p)17.6(r)0(o)28.1(c)13.4(e)12.8(d)16(u)17.6(r)0(e)-266.2(i)15.4(s)-279.5(o)16.2(n)15.6(e)-278.1(o)16.2(f)]TJ 0 -1.2266 TD -.0154 Tc [(th)-15.4(e)-309.5(m)-.3(os)-15.4(t)-308(c)4.3(o)-15.4(m)9.6(mon)-316(b)-.9(eing)-323.3(perfor)-15.4(m)11.6(e)-2.6(d)-315.6(i)0(n)-322.3(o).8(u)-15.4(r)-308.3(facility)-317([)-3.2(6].)-321.8(P)2.2(r)-15.4(i)12(or)-319.6(to)]TJ 0 -1.2203 TD -.0158 Tc [(condu)-15.8(c)8.9(tin)-15.8(g)-314.5(this)-326.9(su)-15.8(r)13.8(v)-15.8(e)8.9(illance,)-328.5(we)-325.5(d)-15.8(i)9.3(d)-322.3(n)-.2(o)-15.8(t)-316.2(have)-325.5(genu)-15.8(i)10.9(n)-.2(e)-325.5(i)-.4(ns)-15.8(i)11(g)-1.2(ht)]TJ T* -.0144 Tc [(into)-320.7(the)-324.1(i)1(ncidence)-324.1(of)-324.7(SSI)-320(af)4.1(ter)-318.6(c)-1(ho)-14.4(l)10.9(e)-1.7(c)5.3(y).2(s)-14.4(t)9.1(e)4.7(c)-1(tomy)-322.3(in)-321.3(o)-14.4(u)13.1(r)-324.9(h)1.2(os)-14.4(p)14.5(i)1(tal)]TJ T* -.0155 Tc [(becaus)-15.5(e)-257(o).7(f)-268.9(t)-3.3(he)-268.3(lack)-266.5(of)-268.9(s)-15.5(y)10.4(stematic)-267.7(monitor)-15.5(i)11.9(ng.)-271.3(T).5(his)-269.7(r)2.8(esearch)-271.8(h).1(as)]TJ 0 -1.2266 TD -.028 Tc [(s)-10.3(e)-15.3(t)-294(c)-14.6(l)-12.6(e)-15.3(a)-8.5(r)-294.3(c)-14.6(r)-28(it)-9.5(e)-15.3(r)-28(ia)-293.1(t)-9.5(o)-296.3(d)-12(e)-15.3()-12(n)-12.4(e)-293.5(r)-28(is)-28(k)-280.3(f)-9.5(a)-14.9(c)-14.6(t)-15.8(o)-11.8(r)-28(s)-276.6(a)-14.9(n)-12.4(d)-296.6(m)-12.9(o)-11.8(d)-12(e)-293.5(o)-11.8(f)-294(p)-28(re)-15.2(v)-28(e)-3.3(n)-12.4(t)-9.5(i)-28(o)-2.7(n)-12.4(.)]TJ 1.1128 -1.2203 TD 0 Tc [(The)-196(overall)-200.4(incidence)-198.6(of)-199.3(SSI)-195.1(was)-198.5(1.44%.)-195.7(The)-202.3(infection)-200.1(rate)-196.6(in)]TJ -1.1128 -1.2203 TD [(open)-190.8(cholecystectomy)-189.5(was)-185.8(6.06%,)-189.4(whereas)-189.7(in)-190.3(the)-187.1(laparoscopic)]TJ 0 -1.2266 TD [(group,)-468.8(it)-465.6(was)-464(only)-469.4(0.6%.)-468.1(As)-464.3(in)-468.5(our)-466.4(study,)-468.7(Richards)-470.2(et)-468.3(al.)]TJ 0 -1.2203 TD [(concluded)-527.7(that)-528.6(SSI)-530.2(rates)-526.7(after)-525.9(cholecystectomy)-537.3(should)-527.5(be)]TJ T* [(stratied)-435.5(by)-426.2(technique)-439.3([8].)-433.3(As)-426.3(expected,)-438.8(most)-432.1(laparoscopic)]TJ 0 -1.2266 TD [(cholecystectomies)-714.6(were)-710.3(elective,)-712(as)-715.3(those)-709.7(patients)-711.8(were)]TJ 0 -1.2203 TD [(younger,)-196.9(had)-189.3(lower)-198.2(ASA)-191(scores,)-197.9(and)-195.6(shorter)-192.6(mean)-196.4(duration)-198.1(of)]TJ T* [(operation)-280(and)-284.1(thus)-284.7(a)-277.7(lower)-280.4(risk)-281.8(of)-281.4(developing)-281.8(SSI.)]TJ 1.1128 -1.2266 TD [(Male)-273.6(patients)-275.5(were)-280.3(ve)-269.2(times)-281(more)-272.8(likely)-278.6(to)-275.1(develop)-276.8(post-)]TJ -1.1128 -1.2203 TD [(operative)-325(infections.)-324.5(We)-321.4(attribute)-327(this)-324.8(to)-319.4(their)-324.1(older)-326.1(age)-320(and)]TJ T* [(higher)-331.5(ASA)-330.1(scores,)-330.7(although)-335(the)-326.2(differences)-340.6(were)-324.6(not)-335.4(statis-)]TJ T* [(tically)-279.8(signicant.)]TJ 1.1128 -1.2266 TD -.0196 Tc [(Pat)-7.4(i)2.2(ents)-425.6(who)-427(h)-4(ad)-427.3(emerge)-6.8(ncy)-428.7(p)-2(roc)-6.2(e)-.5(dures)-425.6(w)-2.3(ere)-424.2(m)-4.5(ore)-430.5(o)2.9(f)-7.4(t)-1.1(en)]TJ -1.1128 -1.2203 TD -.0179 Tc [(treated)-248.5(w)-.6(ith)-248.9(t).6(h)4(e)-251.7(open)-248.9(op)6(erati)3.9(o)-1.7(n)4(.)-248.4(In)-248.9(our)-246.2(e)-5.1(m)3.5(e)1.2(rgency)-249.9(departm)3.5(e)1.2(nt,)]TJ T* -.019 Tc [(general)-420.9(s)-1.3(urgeons)-418.7(r)-.7(otate)-417.2(d)-3(aily,)-420.3(a).5(nd)-420.3(there)-423.6(i)2.8(s)-418.7(a)-423.2(variation)-420.7(i)-3.6(n)-420.7(t)-.5(he)]TJ 0 -1.2267 TD -.0178 Tc [(exten)4.1(t)-296.5(of)-296.5(l)4(a)-4.7(p)6.1(a)1.7(roscopi)4(c)-295.3(experi)4(en)4.1(ce)-295.9(amon)4.1(g)-294.1(t).7(hem)3.6(.)-298.9(E)4.5(m)-2.7(ergency)-294.1(p)-.2(a-)]TJ 0 -1.2203 TD -.0187 Tc [(tients)-190.7(ofte)-6(n)-186.5(h)-3.1(ave)-183(c)-5.3(omplic)-5.3(ated)-186.1(intra-operative)-183()-2.7(ndings,)-192.3(s)5.3(o)-192.2(t)-.2(he)-183(use)]TJ T* -.0184 Tc [(of)-505.7(the)-498.8(o)-2.2(pen)-502.3(a)1.1(pp)5.5(roach)-502.3(i)3.4(s)-500.2(n)-2.8(ot)-499.4(su)5.5(rprising.)-501.9(T)3.9(hese)-498.8(patients)-500.3(had)]TJ 0 -1.2266 TD -.0174 Tc [(h)4.5(i)-2(g)3.5(h)-1.8(er)-296.3(ASA)-303.3(s).3(cor)7.2(e)-4.7(s)6.6(,)-298.5(and)-298.6(t)1.1(hus)-296.9(a)-295.1(hi)4.4(gh)4.5(er)-302.6(ri)4.4(sk)-300(of)-296.1(SSI)5.8(.)-298.5(In)-299(our)-296.3(s).3(tud)4.9(y)-2.8(,)]TJ 0 -1.2203 TD -.0189 Tc [(emergenc)-5.5(y)-371.1(o)-2.7(pen)-376.4(p)-1.3(roce)-6.2(dures)-374.3(h)-3.3(ad)-376(the)-372.9(h)-3.3(ighest)-373.5(infection)-376.4(r)-.6(ate,)-375.9(at)]TJ T* [(9.09%,)-192.5(w)-1.6(herea)-5.8(s)-190.9(elect)-6.7(i)2.9(ve)-189.5(open)-193(pr)5.7(ocedures)-190.9(had)-186.3(a)-195.5(2.27%)-191.2(rate)-195.8(of)-190.1(SSI.)]TJ 1.1128 -1.2203 TD 0 Tc [(There)-215.5(were)-217.1(nine)-218.9(patients)-218.6(between)-218.3(4)-220.8(and)-214.6(18)-214(years)-214.5(of)-218.2(age.)-215.4(All)]TJ -1.1128 -1.2266 TD [(procedures)-345.4(in)-342(this)-343.8(group)-345.7(were)-343.6(elective)-342.4(and)-347.3(were)-343.6(performed)]TJ 0 -1.2203 TD [(laparoscopically.)-661.1(None)-663.6(of)-660.8(them)-658.9(developed)-665.4(infection.)-664.6(As)]TJ T* [(Esposito)-591.9(et)-594.7(al.)-594(reported,)-593.4(pediatric)-593(patients)-598(are)-594.5(more)-595.3(de-)]TJ 0 -1.2266 TD [(manding)-400.5(than)-405.1(adults)-401.2(because)-404(of)-401.6(possible)-403.8(congenital)-405.9(biliary)]TJ 0 -1.2203 TD [(abnormalities;)-364.5(nevertheless,)-371.4(the)-364.2(laparoscopic)-362.7(approach)-368.3(is)-358.9(as)]TJ T* [(effective)-282.9(as)-279(open)-285.6(surgery)-284.7([12].)]TJ 1.1128 -1.2266 TD [(Prophylactic)-310.5(antibiotics)-313.1(were)-311.9(administrated)-313.1(to)-306.7(all)-310.1(patients)]TJ -1.1128 -1.2203 TD [(having)-305.8(emergency)-306.6(procedures,)-304.1(including)-310(those)-305(who)-305(had)-303.1(op-)]TJ T* [(erations)-403.6(\(open)-412.6(or)-401.8(laparoscopic\))-407.4(lasting)-408.2(longer)-406.7(than)-405.1(120)-169.3(min)]TJ 0 -1.2267 TD [(and)-397.9(when)-394(the)-402.1(intra-operative)-402.6(nding)-400.1(was)-394.5(empyema)-398.6(of)-395.3(the)]TJ 0 -1.2203 TD (gallbladder.)Tj 1.1128 -1.2203 TD [(In)-397.5(the)-408.4(28)-403.7(patients)-402(having)-407(laparoscopic)-406.9(cholecystectomies)]TJ -1.1128 -1.2203 TD [(converted)-199.8(to)-199.2(open)-203.4(surgery,)-199.1(the)-199.8(incidence)-204.9(of)-199.3(SSI)-201.4(was)-198.5(17.9%,)-202(the)]TJ 0 -1.2267 TD [(majority)-488.1(\(71.4%\))-484.6(of)-490.1(the)-490.6(procedures)-490.8(were)-482.7(elective,)-490.7(and)-492.8(the)]TJ 0 -1.2203 TD [(operating)-269(time)-267(was)-268(signicantly)-270.1(longer)-274(than)-266(in)-266.2(the)-269.3(other)-272.8(two)]TJ T* [(groups)-713.8(\(109.64)]TJ /F6 1 Tf 7.0311 0 TD ()Tj /F5 1 Tf .7208 0 TD [(85.36)-165.4(min\).)-709.7(These)-715.7(procedures)-718.4(were)-710.3(per-)]TJ -7.7519 -1.2266 TD [(formed)-326.9(more)-329.7(often)-335.8(on)-328.6(male)-329.3(patients)-332.4(\(64.3)-330.7(%)-330.4(vs.)-327.4(35.7%\),)-328.9(and)]TJ ET 95.584 230.57 239.301 .22676 re f 95.584 93.146 239.301 .28342 re f 95.584 201.6 239.301 .22675 re f BT /F8 1 Tf 8.9663 0 0 8.9663 121.096 256.1385 Tm (Table)Tj /F5 1 Tf 3.0666 0 TD (3.)Tj /F8 1 Tf 1.2456 0 TD [(Binary)-337.7(Logistic)-335.6(Regression)-337.8(Model)]TJ -2.4217 -1.1128 TD [(for)-334.5(Prediction)-334.1(of)-330(Infection)-339.9(during)]TJ 3.0666 -1.1065 TD [(Hospital)-338(Surveillance)]TJ /F10 1 Tf -7.8025 -3.1551 TD (Factor)Tj 13.6638 1.1065 TD (Odds)Tj .0126 -1.1065 TD (Ratio)Tj 2.7252 1.1065 TD [(95%)-334.3(Condence)]TJ 1.7262 -1.1065 TD [(Interval)-2302.7(P)-338.1(value)]TJ /F5 1 Tf -18.1278 -2.0992 TD [(Cholecystectomy)-6374.2(4.67)-1803.5(1.04,)-333.2(20.95)-2018(0.044)]TJ 0 -1.1065 TD [(Age)-334.5(of)-338.4(patients)-338.7(\(years\))-3762.6(0.97)-1803.5(0.93,)-333.2(1.00)-2518(0.072)]TJ 0 -1.1128 TD [(Male)-11680.2(5.11)-1803.5(1.49,)-333.2(17.57)-2018(0.010)]TJ T* [(Length)-337(of)-338.4(hospital)-338.3(stat)-330.6(\(days\))-786.9(1.11)-1803.5(1.01,)-333.2(1.22)-2518(0.026)]TJ T* [(Duration)-341.9(of)-332(operation)-336.9(\(min\))-1453.4(1.01)-1803.5(1.00,)-333.2(1.03)-2518(0.033)]TJ 0 -1.1065 TD [(Elective)-339.1(operation)]TJ 1.0053 -1.1128 TD [(\(not)-335.9(emergency\))]TJ 12.8608 1.1128 TD [(0.63)-1803.5(0.11,)-333.2(3.63)-2518(0.601)]TJ -13.8661 -2.2257 TD [(American)-340.4(Society)-337.6(of)]TJ 1.0053 -1.1128 TD [(Anesthesiologists)-338.2(score)]TJ 12.8608 1.1128 TD [(1.77)-1803.5(0.64,)-333.2(4.88)-2518(0.269)]TJ -13.8661 -2.2193 TD [(Antibiotic)-338.9(prophylaxis)-3944.2(0.77)-1803.5(0.12,)-333.2(4.85)-2518(0.779)]TJ /F3 1 Tf 0 76.5136 TD [(SSI)-334.5(AFTER)-337.3(CHOLECYSTECTOMY)]TJ 54.1178 0 TD (3)Tj /F9 1 Tf 9.9626 0 0 9.9626 65.7071 832.4218 Tm [(SUR-)-9.6(2012-096-v)-14.2(er9-Bog)-9.3(danic_1)-8.9(P.3d)-1004.2(03/)-8.6(23/13)-1009.3(11:55am)-1011.6(Page)-337.7(3)]TJ ET endstream endobj 7 0 obj <> endobj 8 0 obj <>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 9 0 obj <>stream 0 0 0 1 k /GS1 gs 0 827.886 23.868 .28345 re f q 1 i 0 863.655 683.64 -863.64 re W n 35.49 839.792 .28345 23.863 re f 647.83 839.792 .28351 23.863 re f 659.735 827.886 23.905 .28345 re f 659.735 35.546 23.905 .28348 re f 647.83 .015015 .28351 23.909 re f 35.49 .015015 .28345 23.909 re f Q 0 35.546 23.868 .28348 re f BT /F5 1 Tf 8.9663 0 0 8.9663 97.8519 761.6124 Tm 0 Tc 0 Tw [(prophylactic)-392.7(antibiotics)-389(were)-381.5(administrated)-389(to)-388.9(53.6%)-382.5(of)-388.9(the)]TJ 0 -1.2203 TD [(patients.)-284.7(Five)-280.5(patients)-288.1(developed)-286(SSI,)-280.2(and)-277.8(of)-287.8(these,)-279.8(antibiotic)]TJ 0 -1.2266 TD [(prophylaxis)-390.8(had)-391.6(been)-387(administrated)-395.3(to)-388.9(only)-387.2(one.)-388.3(Although)]TJ 0 -1.2203 TD [(this)-419.7(is)-415.8(a)-416.8(small)-416.4(number)-418.3(of)-420.6(patients,)-417.5(we)-418.8(believe)-416.6(that)-421.2(at)-417.3(each)]TJ T* [(converted)-421.1(laparoscopic)-419.6(cholecystectomy,)-420(antibiotic)-419.3(prophy-)]TJ 0 -1.2266 TD [(laxis)-281.9(should)-280.9(be)-282.5(considered)-282.4(strongly)-286.6([13].)]TJ 1.1128 -1.2203 TD [(Supercial)-535.5(SS)15.7(Is)-515.6(we)17.4(re)-512.7(t)12.2(h)0(e)-521.8(m)15.1(os)14.9(t)-525.3(o)0(f)22(t)0(e)18.6(n)-528.2(re)18.4(po)21.2(rt)17.8(ed)-515(in)18.4(f)12.2(e)0(c)13.5(t)12.2(io)19(n.)]TJ -1.1128 -1.2203 TD [(We)-409.9(be)21(li)18.2(ev)18.3(e)-417.2(t)0(h)15.1(i)0(s)-409.5(t)12.2(yp)19.5(e)-423.5(o)0(f)-407.9(S)0(S)15.7(I)-413.1(is)-415.8(un)20.5(de)22.4(rr)17.6(ep)17.7(or)21.8(te)18.6(d,)-410.6(be)21(ca)20.2(us)16.3(e)-417.2(p)0(o)14.8(s)0(t)17.2(-)]TJ 0 -1.2266 TD [(di)18.8(sc)18.4(ha)22.4(rg)20.2(e)-682.8(s)0(u)16.3(r)0(v)23.9(e)0(i)15.5(l)0(l)18.2(a)13.1(nc)16.3(e)-676.4(i)0(s)-675.1(d)0(i)25.1(f)0()15.5(c)13.4(ul)14.1(t)12.2(,)-679.5(an)16.1(d)-679.5(s)0(u)22.6(r)0(g)20.2(e)0(o)16.3(n)0(s)-668.6(t)0(e)18.6(n)0(d)-670.3(t)0(o)]TJ 0 -1.2203 TD [(do)19.5(wn)20.3(gr)20.2(ad)16.5(e)-316(t)0(h)15.1(i)0(s)-308.3(t)12.2(yp)19.5(e)-316(o)0(f)-313.1(c)13.4(om)18.6(pl)20.4(ic)16.2(a)13.1(t)0(i)15(o)0(n)19.1(.)-319.1(B)16(i)0(s)14.1(c)13.4(io)19(ne)-313.1(e)12.8(t)-316.6(al)15.9(.)-312.7(r)0(e)18.4(p)0(o)14.8(r)0(t)17.8(e)12.8(d)]TJ T* [(in)18.4(co)16.9(m)15.1(p)0(l)14.1(e)12.8(te)-348.1(po)21.2(st)17.2(-)12.2(d)0(i)18.8(s)0(c)18.4(h)0(a)16.1(r)0(g)20.2(e)-354(f)12.2(o)0(l)19(l)0(o)19(w)0(-)16.9(u)0(p)-344.1(i)0(n)-342(5)0(0)19.9(.)0(5)16.5(%)-349.4(of)-351(a)13.1(b)0(o)18.1(u)0(t)-343.3(6)0(,)16.5(0)13.1(00)]TJ T* [(ch)16.3(ol)19(e)12.7(c)0(y)15.3(s)0(t)23.5(e)0(c)19.8(t)0(o)15.7(m)0(y)-520.5(c)0(a)20.2(s)0(e)17.8(s)0(,)-522.7(w)0(h)20.3(i)0(c)16.2(h)-534.5(in)18.4(di)25.1(ca)13.8(t)12.2(e)0(s)-526(i)0(n)18.4(s)0(u)22.6(f)0()15.5(c)13.4(ie)15.5(nt)-522.3(su)22.6(rv)17.5(ei)15.5(l-)]TJ 0 -1.2266 TD [(la)22.2(nc)16.3(e)-252.8([)0(1)19(4)0(])19(.)-249.5(In)-245.8(ou)21.2(r)-253.6(s)0(t)17.2(u)0(d)20.9(y)0(,)-241.3(t)0(h)15.1(e)-252.8(po)21.2(st)17.2(-)12.2(d)0(i)18.8(s)0(c)18.4(h)0(a)16.1(r)0(g)20.2(e)-252.8(f)12.2(o)0(l)19(l)0(o)19(w)0(-)16.9(u)0(p)-243(r)0(a)18.8(t)12.2(e)-252.8(w)0(a)17.8(s)]TJ 0 -1.2203 TD [(70)19.9(.3)22.9(%.)-333.3(Ou)20.9(r)-342.1(p)0(a)24.4(t)0(e)18.6(n)0(t)15.1(s)-336.4(we)17.4(re)-329.4(mo)18.6(ni)18.4(t)12.2(o)0(r)15.5(e)12.8(d)-344.4(w)0(i)20.1(t)12.2(hi)18.4(n)-338.5(3)0(0)-327.8(p)0(o)14.8(s)0(t)17.2(-)12.2(op)21.2(er)18.4(at)19(iv)21(e)]TJ T* [(da)16.5(y)14.6(s)0(,)-263.5(w)0(h)20.3(i)0(c)22.5(h)-275.3(le)21.9(av)18.7(es)-260.4(op)14.8(e)12.8(n)-268.9(th)15.1(e)-271.8(q)14.6(ue)17.7(st)17.2(io)19(n)-268.9(o)0(f)-262.5(u)0(n)20.5(r)0(e)18.4(p)0(o)14.8(r)0(t)17.8(e)12.7(d)-268.6(c)0(a)20.2(s)0(e)17.8(s)0(.)]TJ 1.1128 -1.2266 TD [(In)-378.6(2010)-383.7(in)-380(Croatia,)-382.6(the)-383.1(rate)-380(of)-382.6(ESBL)]TJ /F10 1 Tf 16.5281 0 TD [(Klebsiella)-389.8(pneumoniae)]TJ /F5 1 Tf -17.6409 -1.2203 TD [(isolates)-221(resistant)-219.3(to)-218.2(third-generation)-225.5(cephalosporins)-220.1(was)-217.4(34%.)]TJ T* [(During)-489(2010,)-487.8(a)-486.4(somewhat)-493.4(higher)-489.5(number)-487.9(of)-490.1(carbapenem-)]TJ 0 -1.2266 TD [(resistant)-408.9(isolates)-404.4(\(mostly)-402.6(resistant)-402.6(to)-401.6(ertapenem)-407.4(only\))-406.6(were)]TJ 0 -1.2203 TD -.014 Tc [(r)-14(e)17(co)-14(r)14.1(d)2(ed.)-250.9(T)-14(h)11.2(e)-254.2(r)4.3(s)-14(t)-237.1(metallo-be)5.1(t)-1.8(a-la)5.5(ctama)5.5(s)-14(e)-242.8(\()4.5(NDM-1\))4.5(-p)-14(r)15.6(o)2.2(d)-14(u)13.3(cing)]TJ T* -.0156 Tc [(is)-15.6(o)11.9(l)-.2(ate)-319(o).6(f)]TJ /F10 1 Tf 4.1731 0 TD -.015 Tc [(K.)-315.1(pneum)-15(o)9.6(n)5.9(i)-15(a)9.1(e)]TJ /F5 1 Tf 6.2091 0 TD -.0136 Tc [(in)-314.2(Cr)-13.6(o)14.5(a)-.5(t)4.9(i)1.8(a)-316.6(w)3.7(as)-312.1(d)-13.6(e)15.1(s)-13.6(c)11.1(r)4.7(i)1.8(bed)-313.8(i)1.8(n)-314.2(200)5.9(9,)-313.7(and)]TJ -10.3822 -1.2203 TD -.0142 Tc [(du)-14.2(r)15.4(i)1.2(n)-14.2(g)-300.2(2010)5.3(,)-314.3(n)1.4(o)-320.5(f)4.3(u)-14.2(r)15.4(ther)-312.1(ND)-14.2(M)10.9(-)4.3(1)-317.2(i)1.2(so)-14.2(l)11.1(a)5.3(tes)-312.7(w)-14.2(e)15.9(r)-14.2(e)-299.3(d)-14.2(e)14.5(t)-2(ect)4.3(e)-1.5(d)-314.4(a)-1.1(mong)]TJ 0 -1.2266 TD 0 Tc [(t)12.2(h)15.6(e)-398.2(o)16.2(rg)26.5(a)13.1(n)15.6(i)15.4(s)17.7(m)15.1(s)-399.7(se)30.4(nt)-389.6(t)18.5(o)-401.1(t)12.2(h)15.6(e)-398.2(R)14.7(e)12.8(f)18.5(e)12.8(r)0(e)24.7(n)15.6(c)13.4(e)-398.2(C)18.8(e)12.8(n)15.6(t)12.2(e)12.8(r)-399(f)18.5(o)0(r)-382.8(r)0(e)24.7(-)18.5(t)12.2(e)12.7(s)17.7(t)12.2(i)15.4(n)15.6(g)-402.8(f)18.5(or)]TJ 0 -1.2203 TD -.0146 Tc [(antibiotic)-279.4(r)-14.6(e)16.4(s)-14.6(i)12.2(stance)-280.1(su)-14.6(r)8.6(v)3.6(eillance)-280.1([)-2.4(15].)]TJ 1.1128 -1.2203 TD 0 Tc [(In)-346.9(the)-345.2(report)-347.3(Surveillance)-349(of)-351(Healthcare-Associated)-354.3(Infec-)]TJ -1.1128 -1.2266 TD [(tions)-194.8(in)-196.6(Europe,)-195.4(several)-201.6(countries)-196.1(report)-195.6(their)-197.7(results)-198.3(using)-197.4(the)]TJ 0 -1.2203 TD [(HELICS)-405.1(protocol.)-408.6(The)-404.6(overall)-402.7(cumulative)-405.6(incidence)-407.2(of)-401.6(SSIs)]TJ T* [(was)-388.2(1.43%)-388.8(and)-391.6(in)-386.3(our)-390.5(study)-389.9(1.44%.)-385.4(The)-392(number)-386.7(of)-388.9(partici-)]TJ 0 -1.2266 TD [(pating)-240.3(hospitals)-244.8(and)-233.5(data)-242.8(collected)-239.3(differed)-238.6(from)-241.8(one)-240(country)]TJ 0 -1.2203 TD [(to)-325.7(another)-332.6(\(3)-328.8(vs.)-327.4(296)-327.3(hospitals;)-329.9(152)-327.3(vs.)-327.4(10,020)-322.9(operative)-331.3(pro-)]TJ T* [(cedures\),)-419.8(which)-415.9(leaves)-422.2(unclear)-418.7(the)-414.7(real)-421(infection)-421.4(incidence.)]TJ 0 -1.2266 TD [(Hospitals)-323.6(performing)-318.3(at)-322.4(least)-320.9(20)-315.2(operative)-318.7(procedures)-326.4(could)]TJ 0 -1.2203 TD [(participate,)-240.2(but)-240.2(we)-241.8(believe)-239.5(that)-237.8(more)-241.2(procedures)-244.2(are)-234.1(required)]TJ T* [(for)-237.9(relevant)-235.8(conclusions)-243.2(to)-237.2(be)-231.9(drawn.)-238.8(Interventions)-243.4(should)-236.7(be)]TJ T* [(parsed)-404.1(according)-401.6(to)-407.9(the)-402.1(urgency,)-402.1(and)-404.2(when)-406.6(a)-397.9(laparoscopic)]TJ 0 -1.2266 TD [(procedure)-464.2(is)-453.8(converted)-465.4(to)-458.5(open)-462.7(surgery,)-458.3(a)-454.8(separate)-464.2(group)]TJ 0 -1.2203 TD [(should)-280.9(be)-282.5(formed)-282.6([16].)]TJ 1.1128 -1.2203 TD [(Minimally)-707(invasive)-714.5(operations)-711.2(carry)-706.5(a)-707.7(lower)-710.4(risk)-711.8(of)]TJ -1.1128 -1.2267 TD [(SSI)-467(than)-462(do)-461(similar)-464.9(procedures)-465.5(done)-464.3(in)-468.5(open)-462.7(fashion.)-466.2(La-)]TJ 0 -1.2203 TD [(paroscopic)-441.8(cholecystectomy)-448.7(has)-440.5(become)-440.1(the)-440(gold)-437.4(standard)]TJ T* [(because)-296.5(of)-294.1(its)-296.2(safety,)-299.9(effectiveness,)-298(short)-299.5(hospitalization,)-297.1(and)]TJ 0 -1.2266 TD [(lower)-318.4(cost)-326.3([7,17,18].)-317.1(However,)-318.4(open)-323.6(procedures)-326.4(can)-318.3(be)-314.1(indi-)]TJ 0 -1.2203 TD [(cated)-248.8(for)-250.5(patients)-256.5(who)-248.1(have)-250.1(had)-246.2(abdominal)-251.2(surgery)-253.1(and)-246.2(thus)]TJ T* [(have)-300.7(intra-abdominal)-309.8(adhesions)-302.7(and)-303.1(those)-305(with)-306.2(recent)-300.8(acute)]TJ T* [(cholecystitis)-440.5(or)-439.8(obstructive)-444.9(jaundice)-438.6([19,20].)-434.8(By)-437.4(conducting)]TJ 0 -1.2266 TD [(this)-432.3(survey,)-428.7(we)-425.2(set)-431.6(a)-429.5(clear)-426.6(basis)-427.4(for)-433.9(SSI)-429(monitoring)-427.2(at)-429.9(our)]TJ 0 -1.2203 TD [(hospital.)-436.1(This)-428.5(study)-434.2(proved)-432.1(that)-433.8(male)-430.5(gender,)-431.5(open)-437.4(chole-)]TJ T* [(cystectomy)-300.7(or)-294.3(laparoscopic)-299.5(cases)-292.2(converted)-301(to)-294.1(open)-298.3(surgery,)]TJ 0 -1.2266 TD [(and)-284.1(prolonged)-281.1(procedures)-282.2(carry)-282.8(a)-277.7(higher)-287.2(risk.)]TJ 1.1128 -1.2203 TD [(The)-227.6(HELICS)-234.4(protocol)-228.6(is)-232.5(a)-227.1(good)-234.3(concept)-234.1(for)-225.2(monitoring)-237.5(SSI,)]TJ -1.1128 -1.2203 TD [(but)-404.6(in)-405.3(case)-404.7(of)-407.9(cholecystectomy,)-413.7(it)-402.3(requires)-410.2(consideration)-409.3(of)]TJ 0 -1.2266 TD [(additional)-344.7(elements)-347.4(such)-340.5(as)-342.3(antibiotic)-343.4(appropriateness,)-348.8(gall-)]TJ 0 -1.2203 TD [(bladder)-671.6(entry,)-669.4(empyema)-670.4(of)-673.5(the)-667.7(gallbladder,)-672.9(obstructive)]TJ T* [(jaundice,)-390.9(previous)-384.7(cholecystitisis)-394.8(or)-382.8(pancreatitis,)-388.9(and)-385.3(previ-)]TJ 0 -1.2267 TD [(ous)-340.6(abdominal)-339.7(operations.)-341.1(The)-335.1(ASA)-342.7(physical)-338.8(status)-339.6(classi-)]TJ 0 -1.2203 TD [(cation)-445.2(is)-441.1(good)-449.2(to)-439.5(estimate)-445.3(the)-446.4(patients)-448.1(overall)-447(health,)-443.1(but)]TJ T* [(some)-450.5(diseases;)-449(e.g.,)-449.3(diabetes)-454.6(mellitus,)-450.4(or)-452.4(some)-450.5(drugs;)-450(e.g.,)]TJ T* [(corticosteroids,)-246(have)-243.8(a)-239.8(big)-240(impact)-242(on)-240.1(the)-244(immune)-243.6(system)-238.9(and)]TJ 0 -1.2267 TD [(thus)-284.7(the)-282(defense)-286.1(against)-277.7(infection.)]TJ 1.1128 -1.2203 TD [(When)-227(laparoscopic)-236.2(cholecystectomy)-233.7(has)-231.8(to)-230.9(be)-231.9(converted)-231.5(to)]TJ -1.1128 -1.2203 TD [(open)-462.7(surgery,)-458.3(antibiotic)-463.5(prophylaxis)-466.6(should)-464.3(be)-459.6(considered)]TJ 0 -1.2266 TD (seriously.)Tj /F3 1 Tf 27.9978 74.5598 TD [(Author)-338.7(Disclosure)-336.7(Statement)]TJ /F5 1 Tf 1.1128 -1.8336 TD [(No)-281(conicting)-288.6(nancial)-280.7(interests)-282.9(exist.)]TJ /F3 1 Tf -1.1128 -3.2563 TD (References)Tj /F5 1 Tf 8.4682 0 0 8.4682 353.14 699.9305 Tm [(1.)-501.9(Wilson)-249.7(J,)-244.8(Ramboer)-244.1(I,)-247.2(Suetens)-249.5(C.)-240.4(Hospitals)-253.3(in)-244.9(Europe)-250.4(Link)-240.5(for)]TJ 1.2519 -1.2385 TD [(Infection)-704.5(Control)-700.4(through)-700.8(Surveillance)-704.1(\(HELICS\):)-703.5(Inter-)]TJ 0 -1.2318 TD [(country)-628.3(comparison)-629.9(of)-623.2(rates)-627.1(of)-629.9(surgical)-625.4(site)-628.6(infection)]TJ 0 -1.2385 TD [(Op)21.6(po)16(rt)17.4(un)20.2(it)20.6(ie)12.6(s)-253.5(a)0(n)14.2(d)-252.9(li)19.7(mi)17.9(ta)18.6(ti)20.6(on)15.1(s.)-244.5(J)-260.5(H)0(o)17.3(s)0(p)-249.6(I)0(n)21.3(f)0(e)13.4(c)0(t)-245.2(2)0(0)15.9(0)0(7)22.6(;)0(6)20.3(5)0(\()18.6(S)0(u)15.1(p)0(p)21.1(l)-261.3(2\))18.6(:)]TJ 0 -1.2318 TD [(16)22.6(5)15.9(17)22.6(0.)]TJ -1.2519 -1.2385 TD [(2.)-501.9(Smyth)-479.6(ET,)-476.8(Emmerson)-479.3(AM.)-473.2(Surgical)-481.3(site)-474.6(infection)-482(surveil-)]TJ 1.2519 -1.2318 TD [(lance.)-337.3(J)-334.1(Hosp)-332.7(Infect)-337.7(2000;45:17318)-7.4(4.)]TJ -1.2519 -1.2385 TD [(3.)-501.9(Mangram)-418.9(AJ,)-425.4(Horan)-420.3(TC,)-419.7(Pearson)-428.1(ML,)-418.3(et)-421.8(al.)-415.1(Guideline)-425.2(for)]TJ 1.2519 -1.2318 TD [(prevention)-290.6(of)-288.5(surgical)-284(site)-287.1(infection,)-292.2(1999.)-287.3(Hospital)-287.7(Infection)]TJ 0 -1.2385 TD [(Control)-312.1(Practices)-318.5(Advisory)-314.3(Committee.)-319.5(Infect)-317.7(Control)-312.1(Hosp)]TJ 0 -1.2318 TD [(Epidemiol)-339.1(1999;20:250278.)]TJ -1.2519 -1.2385 TD [(4.)-501.9(Coello)-514(R,)-510(Charlett)-519.1(A,)-513.1(Wilson)-517.5(J,)-512.6(et)-508.8(al.)-515.5(Adverse)-517.9(impact)-513.5(of)]TJ 1.2519 -1.2318 TD [(surgical)-484.9(site)-488(infections)-487.8(in)-479.3(English)-491.2(hospitals.)-487.6(J)-481.4(Hosp)-486.7(Infect)]TJ 0 -1.2385 TD (2005;60:93103.)Tj -1.2519 -1.2385 TD [(5.)-501.9(Emori)-460.6(TG,)-461.4(Gaynes)-467.7(RP.)-459.3(An)-465.6(overview)-465.9(of)-462.6(nosocomial)-471.3(infec-)]TJ 1.2519 -1.2318 TD [(tions,)-275.8(including)-272.4(the)-278.2(role)-273.2(of)-268.4(the)-278.2(microbiology)-273.3(laboratory.)-279.1(Clin)]TJ 0 -1.2385 TD [(Microbiol)-336.6(Rev)-339.2(1993;6:428442.)]TJ -1.2519 -1.2318 TD [(6.)-501.9(HELICS)-258.5(protocol,)-253.1(Version)-261(9.1.)]TJ /F10 1 Tf 14.6415 0 TD [(Available)-258.5(at)]TJ /F5 1 Tf 5.0144 0 TD [(http:/)226.1(/helics.univ-)]TJ -18.404 -1.2385 TD [(lyon1.fr/protocols/ssi_protocol.pdf.)-796.1(Accessed)-777.5(January)-780.3(4,)]TJ 0 -1.2318 TD (2012.)Tj -1.2519 -1.2385 TD [(7.)-501.9(Kasatpibal)-391.6(N,)-394.2(Thongpiyapoom)-395.4(S,)-388.2(Narong)-397.2(MN,)-387.7(et)-395(al.)-388.3(Extra)]TJ 1.2519 -1.2318 TD [(charge)-292.8(and)-292.3(extra)-292.1(length)-299.2(of)-288.5(postoperative)-301.1(stay)-292.1(attributable)-297.9(to)]TJ 0 -1.2385 TD [(surgical)-270.6(site)-273.7(infection)-274.5(in)-271.7(six)-265.9(selected)-278.4(operations.)-272.6(J)-273.8(Med)-267.2(Assoc)]TJ 0 -1.2318 TD [(Thai)-332.6(2005;88:10831091.)]TJ -1.2519 -1.2385 TD .0241 Tc [(8)24.1(.)-477.8(Ric)5.9(h)-6.4(ards)-637.8(C,)-636.4(Edwards)-637.8(J)4.7(,)-643.1(Culver)-635.3(D,)-636.4(et)-638(al.)-636.4(D)-2.6(oes)-637.8(u)1.2(sin)-6.4(g)]TJ 1.2519 -1.2318 TD .0235 Tc [(a)-688.3(l)-3.5(aparo)-4.6(s)4.3(co)-4.6(pic)-684.3(a)1.3(p)-6.1(p).6(roa)-5.4(c)-1.4(h)-689.9(t)4.1(o)-694.1(c)]TJ 14.7553 0 TD .0244 Tc [(h)-6.1(o)3(lecyst)5(ectomy)-688.9(decrease)]TJ -14.7553 -1.2385 TD .0236 Tc [(the)-546.1(r).2(isk)-549.1(o)2.2(f)-551.5(s)4.4(u)-6(r).2(gical)-552.3(s)-2.3(ite)-546.1(i)-3.4(nfection?)-550.3(A)-3.1(nn)-549.2(Surg)-549.1(20)-5.3(03;237)-5.3(:)]TJ 0 -1.2318 TD .0222 Tc [(358)-6.7(362.)]TJ -1.2519 -1.2385 TD 0 Tc [(9.)-501.9(Keats)-334.3(AS.)-334.5(The)-337.7(ASA)-336.7(classication)-343.6(of)-335.4(physical)-338(status:)-334.3(A)-334.6(reca-)]TJ 1.2519 -1.2318 TD [(pitulation.)-337.8(Anesthesiology)-344.5(1978;49:233236.)]TJ -1.754 -1.2385 TD .8011 Tc [(1)801.1(0)801.1(.)297.1(C)779.4(u)778.2(l)774.1(v)774(e)780.4(r)1.1(D)774.4(H)779.6(,H)779.6(o)773(r)777.7(a)778.9(n).7(T)775.8(C)779.4(,G)777.8(a)778.9(y)777.3(n)777.3(e)773.7(s)5.3(R)777.5(P)771.5(,)6.7(e)773.7(t)5.1(a)772.2(l)780.8(.S)778.8(u)778.2(r)777.7(g)777.3(i)774.1(c)776.2(a)778.9(l)]TJ 1.754 -1.2318 TD .0252 Tc [(wound)-415.2(i)-1.8(nf)5.8(ecti)4.9(on)-413.7(rates)-415.7(b)1.4(y)-420.3(w)1.3(ound)-421.9(c)7(l)-1.8(ass,)-414.4(ope)4.5(r)1.8(at)5.8(ive)-417.3(p)2.3(roce-)]TJ 0 -1.2385 TD .024 Tc [(dure,)-844(a)1.8(nd)-844.9(patient)-845.7(r).6(isk)-850(i)3.7(ndex.)-844(N)-4.2(ational)-846.5(N)2.5(osocomial)]TJ 0 -1.2318 TD .0235 Tc [(Infe)-3.9(ctions)-390.7(S)-5.5(u).6(rveillance)-392.2(System.)-396(A)3.5(m)-393.6(J)-390.9(Med)-390.1(1)-5.4(991;91:1)-5.4(52S)]TJ 0 -1.2385 TD .0222 Tc [(157)-6.7(S.)]TJ -1.754 -1.2318 TD 0 Tc [(11.)-504(Horan)-252.9(TC,)-245.6(Gaynes)-246.8(RP,)-251.7(Martone)-251.7(WJ,)-249(et)-247.7(al.)-247.7(CDC)-250.9(denitions)-253(of)]TJ 1.754 -1.2385 TD [(nosocomial)-384.3(surgical)-377.7(site)-380.9(infections,)-385.1(1992:)-374.4(A)-381.5(modication)-380.3(of)]TJ 0 -1.2318 TD [(CDC)-271(denitions)-273.1(of)-275.1(surgical)-270.6(wound)-278.1(infections.)-271.2(Infect)-277.5(Control)]TJ 0 -1.2385 TD [(Hosp)-339.4(Epidemiol)-332.4(1992;13:606608.)]TJ -1.754 -1.2318 TD [(12.)-504(Esposito)-403.3(C,)-394.3(Gonzalez)-397(Sabin)-400.2(MA,)-399.6(Corcione)-398.5(F,)-396.4(et)-401.7(al.)-395(Results)]TJ 1.754 -1.2385 TD [(and)-854.6(complications)-858.8(of)-850.9(laparoscopic)-861.8(cholecystectomy)-859.6(in)]TJ 0 -1.2318 TD [(childhood.)-338.1(Surg)-333.3(Endosc)-340.8(2001;15:890892.)]TJ -1.754 -1.2385 TD [(13.)-504(Widdison)-293.6(AL,)-297.4(Pope)-295.5(NR,)-297.2(Brown)-291.9(EM.)-297.8(Survey)-294.2(of)-295.2(guidlines)-296.9(for)]TJ 1.754 -1.2318 TD [(antimicrobial)-518.6(prophylaxis)-513.5(in)-512.7(surgery.)-516.3(J)-508.2(Hosp)-513.5(Infect)-518.5(1993;)]TJ 0 -1.2385 TD (25:199205.)Tj -1.754 -1.2318 TD [(14.)-504(Biscione)-503.9(FM,)-497.1(Couto)-501.8(RC,)-504.9(Pedrosa)-503.2(TM.)-498.6(Accounting)-506.5(for)-499.3(in-)]TJ 1.754 -1.2385 TD [(complete)-601(postdischarge)-601.1(follow-up)-607(during)-594.7(surveillance)-607.3(of)]TJ 0 -1.2318 TD [(surgical)-484.9(site)-488(infection)-488.7(by)-482.7(use)-484.6(of)-489.4(the)-485.8(National)-485.8(Nosocomial)]TJ 0 -1.2385 TD [(Infections)-502.7(Surveillance)-503.3(systems)-502.8(risk)-501.6(index.)-495(Infect)-505.1(Control)]TJ T* [(Hosp)-339.4(Epidemiol)-332.4(2009;30:433439.)]TJ -1.754 -1.2318 TD [(15.)-504(The)-438.1(Croatian)-435.5(Academy)-440.2(of)-435.8(Medical)-435.2(Sciences.)-442.4(Antibiotic)-441.2(re-)]TJ 1.754 -1.2385 TD [(sistance)-357.2(in)-352.1(Croatia)-358.1(2010.)-347.6(Zagreb.)-356(The)-351.1(Croatian)-361.9(Academy)-353.2(of)]TJ 0 -1.2318 TD [(Medical)-334.8(Sciences.)-342(2011,)-334.2(154)-334.4(pp.)]TJ -1.754 -1.2385 TD [(16.)-504(European)-410.3(Centre)-411(for)-412.3(Disease)-410(Prevention)-411.1(and)-406.1(Control.)-416.9(Sur-)]TJ 1.754 -1.2318 TD [(veilance)-334.1(of)-322(healthcare-)-13.4(associated)-328.6(infections)-333.8(in)-332(Europe,)-328.5(2007.)]TJ 0 -1.2385 TD [(Stockholm.)-337.7(The)-337.7(Centre.)-335.1(2012.)]TJ -1.754 -1.2318 TD [(17.)-504(Varela)-508.8(JE,)-511.1(Wilson)-510.8(SE,)-507.2(Nguyen)-511.4(NT.)-513.2(Laparoscopic)-512(surgery)]TJ 1.754 -1.2385 TD [(signicantly)-374.2(reduces)-371.4(surgical-site)-369.7(infections)-380.6(compared)-370.4(with)]TJ 0 -1.2318 TD [(open)-336.6(surgery.)-335.6(Surg)-340(Endosc)-334.1(2010;24:270276.)]TJ /F3 1 Tf 8.9663 0 0 8.9663 97.8519 785.4801 Tm (4)Tj 45.6704 0 TD [(BOGDANIC)-333.5(ET)-338.7(AL.)]TJ /F9 1 Tf 9.9626 0 0 9.9626 65.7071 832.4218 Tm [(SUR-)-9.6(2012-096-v)-14.2(er9-Bog)-9.3(danic_1)-8.9(P.3d)-1004.2(03/)-8.6(23/13)-1009.3(11:55am)-1011.6(Page)-337.7(4)]TJ ET endstream endobj 10 0 obj <> endobj 11 0 obj <>/ProcSet[/PDF/Text]/ExtGState<>>> endobj 12 0 obj <>stream 0 0 0 1 k /GS1 gs 0 827.886 23.868 .28345 re f q 1 i 0 863.655 683.64 -863.64 re W n 35.49 839.792 .28345 23.863 re f 647.83 839.792 .28351 23.863 re f 659.735 827.886 23.905 .28345 re f 659.735 35.546 23.905 .28348 re f 647.83 .015015 .28351 23.909 re f 35.49 .015015 .28345 23.909 re f Q 0 35.546 23.868 .28348 re f BT /F5 1 Tf 8.4682 0 0 8.4682 95.5842 761.6124 Tm 0 Tc 0 Tw [(18.)-504(Romy)-318.4(S,)-314.6(Eisenring)-321.1(MC,)-314.3(Bettschart)-325(V,)-310.7(et)-321.3(al.)-314.7(Laparoscope)-320.1(use)]TJ 1.754 -1.2318 TD [(and)-406.1(surgical)-411.2(site)-414.3(infections)-414.1(in)-405.6(digestive)-417.7(surgery.)-409.2(Ann)-409.1(Surg)]TJ 0 -1.2385 TD (2008;247:627632.)Tj -1.754 -1.2318 TD [(19.)-504(Subhas)-254.7(G,)-255.3(Gupta)-251.4(A,)-252(Bhullar)-258.6(J,)-251.5(et)-254.4(al.)-254.4(Prolonged)-256.5(\(longer)-253.2(than)-256.7(3)]TJ 1.754 -1.2385 TD [(hours\))-458.2(laparoscopic)-460.1(cholecystectomy:)-455.7(Reasons)-458(and)-452.9(results)-11.2(.)]TJ 0 -1.2318 TD [(Am)-330(Surg)-340(2011;77:981998.)]TJ -1.754 -1.2385 TD [(20.)-504(Van)-459.5(der)-457.7(Steeg)-461.7(HJ,)-460.5(Alexander)-463.1(S,)-455.1(Houterman)-465.3(S,)-461.8(et)-455.2(al.)-461.9(Risk)]TJ 1.754 -1.2318 TD [(factors)-310.6(for)-311.9(conversion)-313.1(during)-313.5(laparoscopic)-319.5(cholecystectomy:)]TJ 0 -1.2385 TD [(Experiences)-374.8(from)-367.5(a)-370.3(general)-369.1(teaching)-373.1(hospital.)-374.7(Scand)-366.3(J)-367.6(Surg)]TJ 0 -1.2318 TD (2011;100:169173.)Tj 8.9663 0 0 8.9663 475.0865 761.6124 Tm [(Address)-339.4(correspondence)-340.1(to:)]TJ /F10 1 Tf 3.7115 -1.2203 TD [(Dr.)-333.8(Branko)-334.8(Bogdanic)]TJ -.8346 -1.2266 TD [(Department)-337.8(of)-336.3(Surgery)]TJ -6.3925 -1.2203 TD [(University)-333.6(Hospital)-339.5(Centre)-333.7(and)-332(School)]TJ 2.2257 -1.2203 TD [(of)-336.3(Medicine)-335.4(University)-340(of)-330(Zagreb)]TJ 7.7203 -1.2266 TD [(Kispaticeva)-334.9(12)]TJ -3.6294 -1.2203 TD [(10)-334.1(000)-333.6(Zagreb,)-339.7(Croatia)]TJ -4.3312 -2.0549 TD (E-mail:)Tj /F5 1 Tf 3.2626 0 TD (dr.bogdanic@gmail.com)Tj /F3 1 Tf -44.058 12.0578 TD [(SSI)-334.5(AFTER)-337.3(CHOLECYSTECTOMY)]TJ 54.1178 0 TD (5)Tj /F9 1 Tf 9.9626 0 0 9.9626 65.7071 832.4218 Tm [(SUR-)-9.6(2012-096-v)-14.2(er9-Bog)-9.3(danic_1)-8.9(P.3d)-1004.2(03/)-8.6(23/13)-1009.3(11:55am)-1011.6(Page)-337.7(5)]TJ ET endstream endobj 13 0 obj <>stream 8;X]O>EqN@%''O_@%e@?J;%+8(9e>X=MR6S?i^YgA3=].HDXF.R$lIL@"pJ+EP(%0 b]6ajmNZn*!='OQZeQ^Y*,=]?C.B+\Ulg9dhD*"iC[;*=3`oP1[!S^)?1)IZ4dup` E1r!/,*0[*9.aFIR2&b-C#soRZ7Dl%MLY\.?d>Mn 6%Q2oYfNRF$$+ON<+]RUJmC0InDZ4OTs0S!saG>GGKUlQ*Q?45:CI&4J'_2j$XKrcYp0n+Xl_nU*O( l[$6Nn+Z_Nq0]s7hs]`XX1nZ8&94a\~> endstream endobj 14 0 obj [/Indexed/DeviceRGB 255 13 0 R] endobj 15 0 obj <> endobj 16 0 obj <>stream hT?0 w>V PUb*CbPÉL!V_~sDZ2ą`H3vahQRUt ܭǩBUe cQ-3kdC#lnohts8!yȡA㐉[DʤhqvR!K}YUD?iE8 1- 7κ82_ݤj endstream endobj 17 0 obj <>stream hbd`ad`ddruvvL) άg9yk߹@H0083MbdbSϥ?3EaY(]g%?Y ye&f endstream endobj 18 0 obj <> endobj 19 0 obj <>stream h޴WgxgEJ"ՐYPIC0por%YmYjI䊫 )`CLOBBB !ޔM¦~>w a%?}BhBBBܸ~-[[Z/.DN.#A)?:l?_P?FB<6e4y-f[ f>]q P:eI&0g|~.$aU:\}FC|.`PCz " QFVV 40;l$,in Xi{={0&&ă$YJx;\;v WY$3kQ&&&lruI$GD"JVΊv7{h:A-Ա_Rh1tl:]a >щ> 4>ȷagg/qvйΞcѫ WF΋ۉ-~~šĕKeW++i2i(g (O?f}*~+ҹrqgלjimt :ЛdQ%Zd_gk@?>pvr!&S]^yv$Cǿ/WUgSE?^[yCعY J298aO4vcЈ)SiPW(r5u]e0 `` VG!k@3, Ԇ- ,[=!T77o}v6ꀧS)g"9+8.,~9k#{c5hdF{_>gZ%뷺 cx?ԟ]c0yd<:qo EZ}@ c'i0tb&Hb,9[^O THJ8'A BhaPh:+[kyp}LdDЙ싑yh+ El V.5t"^汌Mf`h mW &~ȷk^tp;u]cȸa>+ZOΏɉ ~~ qF-ahB0rL aNuSa%XR_+ ei3X*Sii1 ;3z1JN;Ks aaxDS0=ga|0s VAn$gQnpˀ|#GpV}TgtktzPNY`u:# f[M- B,0 Q<420P RrI4ߺ: P҄a:04E%$hRɜ9*0V/ğyΚM,yXj"C@Ʈ#ƣ董 ԸU"i/javYdj 9xDue7 @<NK ·z@d>G p0Bfµ G>#z#v=z'AO;#ach~/4.csy7I}I$=j)-Dis zv~`8Jn2MbJ=eNcgL#ͰA @@߁{ UZT4R/eGsu"P`2} gi? tQ1$"JLZ[.2 &(? p^vulTa rL)x*:V -#r}!^Y>Z u~1 ʍl"CRN%wR2=2ǾY #_ w,&p5\lK'P-SyQV_muWϼm|"#rfZ?)0qE`8j {IZ>'[GCY-zwsžz9J6xylg>JG>!4,:pm0vI"c11_]擶^W7ßOO#Em?.>χȜu[F9[8_Bhy,%1< >}u{ mv _={,q|#1XRRT[nSS\}B^.x1z1 u X_(F)dv24DfHD,.R.ރZ}A{)Ԑ'?{$G?@'Afk*<M/8M^fS 8][/Me ׯ]G8Rqqq9e) *=Nqd2Tjس߃#4;*mQ>jq2ļ dp}Z֎HvD>F\ Dj{_q {V h@g 3)L0o=讱t4 _a2㐮/.B,5}Mk|H\wn? .J޺MUmvX0Gw啡aFg@c"8 ˜Bif5|]+dѫ*bMW`ώAъK}h i֟(s*Y&.'z y|އnVFhy{5)#А-[?p`{7[U#Q@yi;Su%CnՃgovbXV ̭r*K&Q Elgɲ lcgf$KPl5*rΞIO.l<4: qF[ZBnD+_ L1!Uە5M&έ 9B"QPeWSd6-@ -~zudJ[e%rRyqҸ߿xs GU-*D2Q@=diܯîrB۽؄D1-ɐPpl5W,^W<Lۛnvmj).f6IzyZ-YI.S)UJXY$+X|iB[E儏9n+%;4rRs]M-@PƏd79=~l9I9>(Jk@Y#V0<']f}l?[ 7ǘ9x(?A HݶYx{FYj$I(H+v5%9>v&ȅ[DQۖ7^ѫ^`|ٗqC+ԠOHi!H&#+Vې[Gu:եE,E*C@5O9Jk=5vY^YQC|D5vgePWo;di(C*!wU|x'+GsupvSWGMs1*n9GrI$.B^Pm/L ؘ58jz`~^RfA w~u2+Z\W&uݺ/N25؁Br\`Ug [7=N;[_G]9\f{lH.-PaZ ?N\ZbtB8CG5G_|paŶ{#wSOJr8$-" %dq8.\ufjڼ}+,ʓP& •>cE %k1[Ess,0:nαU*#$]mlfSpB06tY&ƤFcӅXAvV|Q2{ǠpE㗻S9.V'bUBpYl,[u 1|Um-ס:qxu> endobj 21 0 obj <>stream h,LJ@N:D:pqrֶrw\b~.R+qgH5*7|Zt]ot;ݝݳˣi-ꛓ<5ׯe`w*jjmma@g@gCYɍO4W 2YAR"B,(v\`+BDDRBӼ%3`ߋ^Z5.:#wnLs;3abqB @z!SL@OkԤ endstream endobj 22 0 obj <> endobj 23 0 obj <> endobj 24 0 obj <> endobj 25 0 obj <> endobj 26 0 obj <>stream 8;Z\7fjVc@%.u=RA,f]g3]/&&/Ii/Y[!o/%N^OUKQN9?;$n(R4:8CLlTLb&0AIm4/ YLlcM7h'0XpRp%/G?KR^Bm";:]O;t.b?Q;;EeThBV&b\_bSOUelU1*o/O,3OC9FIH BuDSsIP_\SXD)aQT0^hR8"os(F<[h)bhD$do&">#lLH$ZnrXI/@J;D2P784?$:jqK il]LWEDF[j0%*$"cM\S:DMifbM7i<8SdG5W+Bt5b'aap2DW$5g^V*.p&LFuM#aKP= =%6-i HUR`@^;)BlWjb5VT1##(K/Yu2a_JOpJ9E2N'Qin7'J.2WYAMGd=Q!a"bCR!ALR&AW L=I!!g%'^HIBalA#&hG,)7A=`WXGFT[iM!bNL6]sCj"_2X'4(9ENPhW73C&e(:HSg qCsO$AMX7?3PXY?FMfbCm*pZt_PEH0M-nPA\_UHVq^q`#m=(od'&uMPFY,':795)` Q1u'.PQr/Fc"EN7\eaRXKlZe^TEqGXBI$Mo"AKA6@fi: endstream endobj 27 0 obj <>stream 8;Z\7=dF[o%-'&>q6G(6*lQYJZ9_q>B>I>)o."&fAJ7Cm%7NYf<5Td/RiWl;[3DHb #.Fd#mp=^R;58b%h\QUZq7JIk+Qn/41(-Ut!4^EH_,O821*ZBNhiF`Am8Q2@R9YXh 2]%5h9q5<8,25O-le7P<;hLu)QuS`cAJDOEmX<]-D$`4QSl]Tppita%(kM_6G,\KK,6!rBuZLVTR-+/kbV)G`F"Ds)q_6`'R>82'p--cPu[en !1.j"/-~> endstream endobj 28 0 obj <>stream 8;Z\79,2C8gF *96e0l1H9G]j?8eX;3TgP#`_W;JQ(a?+CkQWKeIG\;sZr/[i1(: gJt>'8WWc>A@_Ms_O4ngh[1^ECoAt><#fPu&uro%WHe74)*hQ3Z7eL76TnCOk#n1S AdbTOdD-MHBq/)"-/ik>b;/beHq>F>9=9h=^4]+r4t[hb!_i0%M9s;>Y#EkDQThQe .>3Ag>?^'r=(eMa?od:@p@Mq-!f_DrqsYIZ0!?i//A>).<4jkQq,=Yb.Zpi>)HjAN pIkS:9%faA+Vf^(U(Y^7Q;3lNTkJ.DD>\`&k73dk0ZZ$@JIiGC8[`q*SioY0H45\c '\Be`L+e7JlAU@F\B4uKYahqE1\GaHMHB(=n/.GfSUCr]iui?PB/@dL0(VYmg@h#0 ?Gc%_G/s`AU4!Q2_rAQX;qGN+)a$XBop@Bi/WF,'.X)G.:4CE##MIQLpG\VdpCZFh 4^SL9bgqI/GTWQ.8tj_'q_q$;NeOR?-.gSP-7\aMED=PT+0RdVIec&?>)F/4j?`Wj ?g;PLcRmq=CG-1"0+V+&N/n&h[B%ijc`-b*Hm`/T3aeDK4=a3IG!N-uc7Ju"!9)Y2r;~> endstream endobj 29 0 obj <>stream 8;Z\7>EXXn#g?`Tj8N]M3ih5%N.shZcH"M?AOUeWZ-tO[L^:N72I=QfQZ-+E\id(0 jU]]#=h!/&(_9jE#aN)@$1G/nM":ro6hd,SYq"q2f4>R@: 3c;KMZ/"6XlVs*9"Q)&OWggXBB67-`Yo[qI"TEhQ/l4F1*mA1P^W,3l,$sOp!dc5[ Z9.1C?m%;m(c1VK78U3f2OIA<]Zau2ZT#+)HlR*Is(k/j0E=F=YO>WeK)HL=:O'OR I&qP>7N^eTZ;;&faGaGkas53'QMY9YNa>IIPW$hTb!P5NpIk3)+YVS5\KE*0jHum( "1bR1>!7C;H!V1[c>ej^fKk]Xc:"83FK0u;$S46\S6-F\m^(F]_h hI>eb9%?4JL%>RUVNVM`h=t4Q-#/ZpVjO(pn5f]_-U]i0F!%>AI`u`a'tI86=`oCa o+paR>j=:mEtot8qGSsap87&u(p=jJnWZdte=9)tb!'j!*0#_#/j F].tip."e#ffc^%%ee(%&@jWumPqi9_m8hGH/K9'7_etFY[l7\4+MjJRm`%e\Vm'% Um?tFTrN;[C46u@+&@k3>HC5OC/ZG+U&4d7brZTh-rqOpMlK>sh=)4"Qro2i[i7]0 IPoWub!E"fMXZTRZ!gdGNe!up"Wq0Pk@U,@^:fW-MA'hs^n"ETWT,Y7)#P(09ubc#lZ r%5N)Gd9YL7b-JY1Jf:@G1Q9;Dck&BlStGMDi'G endstream endobj 30 0 obj <>stream 8;Z\tlOC`S%"pc;rn[R[Gb&=1]HF#WE\"Q/%p;@/\N#@1<>CtB&m=cNdH!\e6dQ9Z kHhHe@Znsj:9+:J4EcnUtqQ9@/ E-&O$Y@dBGFnK#OC3 endstream endobj 31 0 obj <> endobj 32 0 obj <> endobj 33 0 obj <> endobj 34 0 obj <>stream 2013-03-23T11:54:27+05:30 Arbortext Advanced Print Publisher 9.0.114/W 2013-03-23T11:54:27+05:30 Acrobat Distiller 8.1.0 (Windows) application/pdf untitled uuid:2bb95a71-63f2-43da-857a-7a116c2b61a1 uuid:52ac3a3a-211a-443c-add4-240130ee0c14 endstream endobj 35 0 obj <> endobj xref 0 36 0000000000 65535 f 0000037468 00000 n 0000037620 00000 n 0000037776 00000 n 0000049922 00000 n 0000050074 00000 n 0000050230 00000 n 0000069501 00000 n 0000069653 00000 n 0000069767 00000 n 0000087931 00000 n 0000088086 00000 n 0000088201 00000 n 0000090579 00000 n 0000091093 00000 n 0000091141 00000 n 0000091349 00000 n 0000091636 00000 n 0000091838 00000 n 0000091893 00000 n 0000097691 00000 n 0000098079 00000 n 0000098502 00000 n 0000098700 00000 n 0000099342 00000 n 0000099496 00000 n 0000099664 00000 n 0000100416 00000 n 0000101228 00000 n 0000102100 00000 n 0000103259 00000 n 0000103688 00000 n 0000103724 00000 n 0000103749 00000 n 0000103827 00000 n 0000107366 00000 n trailer <> startxref 116 %%EOF